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ABSTRACT 
Systematic Data-Driven Modeling of Cellular Systems for Experimental Design and 
Hypothesis Evaluation 
 
He Zhao 
Bahrad A. Sokhansanj, Ph.D. 
 
 
 
 
Despite the rapid growth in biological information, drug development is still limited by 
our ability to understand complex cell systems that are involved in diseases. The need to 
model complex cell processes at many different scales requires (a) quantitative 
measurements from experimental techniques in cell biology and (b) mathematical 
modeling approaches to organize and structure information, test and validate hypotheses 
for the new phenomena. The goal of my thesis work was to maximally obtain and 
interpret information on the dynamic behavior of cellular systems using an optimal 
combination of computer simulations and experimental observations. I focused on two 
realistic biological problems to develop and demonstrate methods to generate high 
quality hypotheses through mathematical modeling to define the optimal next step for 
experimental and clinical trial design: (1) I developed a hybrid stochastic model to 
simulate microtubule dynamics and anti-cancer drug effects on microtubules. Model 
parameters were taken directly from experimental observations, and model validation 
was conducted against published experimental data. Our work revealed limitations in 
previous experimental methods to measure microtubule kinetics. (2) I developed a 
quantitative biological system modeling scheme to interpret flow cytometric data, and I 
xi 
 
 
validated this method experimentally. To do so, I designed a novel combination of 
protocols, assay technologies, and data analysis techniques to obtain plausible flow 
cytometric data. Multiple mathematical methods and reversed engineering methods, such 
as parameter estimation, sensitivity analysis, nonlinear regression, Akaike Information 
Criterion (AIC) were integrated to use a data-driven modeling to distinguish between 
different biological hypotheses. Our modeling and validation methodology can be 
generalized to apply to other biological problems with limited data. 
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CHAPTER 1: OBJECTIVES AND OVERVIEW  
Inflammation is a phenomenon involving the activation and migration of different cell 
types, release of signaling factors that induce other cells to become activated or undergo 
apoptosis, and processes that can induce oxidative stress by generating free radicals (i.e., 
reactive oxygen species (ROS)). While inflammation represents the immune response to 
acute infection, it is also engaged as a result of trauma, hypoxia, heat or cold shock, and 
exposure to cigarette smoke and pollutants. Inflammatory pathways are also stimulated in 
metabolic disorders and diabetes. Since inflammation is a response to cell damage, and 
inflammatory processes can themselves damage cells, there are anti-inflammatory 
pathways that are activated to provide a negative feedback so inflammation can end 
(“resolve”) [1]. If that does not happen, chronic inflammation can result and lead to 
chronic disease. 
One example is Chronic Obstructive Pulmonary Disease (COPD: also known as 
chronic bronchitis and emphysema). COPD is currently the 4th leading killer in the 
United States, responsible for more than 110,000 annual deaths and $15 billion in direct 
medical care costs with more than 500,000 hospitalizations [2]. In COPD, as in all 
chronic inflammatory diseases, there is an increase in local (i.e., lung) and systemic 
inflammatory markers over time, leading to an increase in ROS [3]. There is also a 
correlation between elevated inflammatory markers and faster decline in lung function 
[4]. ROS can damage cell components, including DNA, which can lead to mutations, and 
it can also change protein function and increase the proliferation of cells, both of which 
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are factors that may lead to carcinogenesis. Indeed, chronic inflammation is a major risk 
factor for cancer, as reviewed in [5, 6].  
The pivotal role of oxidative stress in the disease process suggests treating disease 
by reducing the levels of ROS with antioxidants, such as N-acetylcysteine (NAC), a 
precursor for glutathione that can be applied clinically [7]. However, these efforts have 
largely failed in clinical trials for diseases like COPD [8], highlighting the contradictory 
nature of in vitro and in vivo results of applying antioxidants to cell and tissue response 
to stimuli. These contradictions can be ascribed to differences in cell type for in vitro 
experiments, the complexity of dosing and metabolism in the whole organism, stimulus 
conditions, doses, and experimental time courses. 
New biological technologies such as rapid genome sequencing, microarrays that can 
analyze the expression of every genes, and methods to analyze the level of thousands of 
proteins simultaneously allow the generation of large amounts of biological data. 
However, the translation of data to drugs has been slowed by the reality that human 
disease is more complex than we thought: there is not a single “high blood pressure” gene 
or “cancer risk” gene, instead diseases are the function of large networks of interacting 
genes and proteins that respond to environmental stimuli [9]. As shown in Figure 1.1, an 
ideal model is difficult to obtain because we have to faithfully simulate the 
complementary patterns of system perturbations on genomic level, protenomic level, 
molecular level, and the overall physiological level [10]. The general challenge is how 
can we understand and interpret these multi-scale biological data and ultimately develop 
3 
 
 
predictive models of human disease. Therefore, systematic level understanding of human 
disease is the keystone for future drug discovery research [11].  
 
 
 
 
Figure 1.1 Different approaches to systems biology in drug discovery, suggesting a 
top-down approach from physiological response and a bottom-up approach from 
molecular pathways and “Omics” technologies (i.e., genomics, proteomics, 
metabolomics).  
 
 
 
Modern systems biology focuses on the studies of many organisms from bacteria to 
man using many different approaches and models [11]. The goal is to develop predictive 
models to understand the physiology and disease from the level of molecular pathways, 
regulatory networks, cells, tissues, organs and ultimately the whole organism [9]. In this 
thesis, I aim to innovate, refine, and validate mathematical and engineering methods to 
understand and integrate multi-scale biological data through experimental modeling and 
computational modeling.  
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It has been previously proposed that approaches to mathematical and computational 
modeling in biology can be thought of as falling into two philosophical categories 
[12-14]. As shown in Figure 1.2, the first approach is “bottom-up modeling”. It is built on 
the mechanisms of systems and aims to approximate the size and complexity of real 
biological systems. Complementary to this approach is top-down modeling. It employs 
mathematical and computational approaches to develop the simplest possible models that 
capture the key features of biology data that are needed for a particular application, such 
as predicting the effect of a drug that targets a particular system component on the system 
function as a whole. Because it is defined by available biological data, we also refer to 
top-down modeling as data-driven modeling. 
 
 
Mechanisms
Estimate the size and 
complexity of real biological 
systems
mathematical &. 
computational 
approaches
Develop the simplest 
possible models that capture 
the key features of biological 
data  
Figure 1.2 Top-Down and Bottom-Up modeling are both contrasting and 
complementary approaches in mathematical and computational modeling in biological 
research.  
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As suggested by Kell, el at, many areas of biological study are data-rich but 
hypothesis-poor [12]. Modeling should be led by hypotheses, but the system models 
cannot be easily compared to a “biological ground truth” were we lack knowledge about 
how the systems work in reality. Data-driven modeling starts with what is known and can 
be measured, which allows for accurate and comprehensive validation. In this study, an 
overall research methodology is investigated to develop a data-driven modeling for 
experimental design and hypothesis evaluation in cellular systems. In the meanwhile, 
multiple methods are employed to provide means of generating novel hypotheses. Two 
realistic biological problems are used to show how to generate high quality hypotheses 
through mathematical modeling to define the optimal next step for the experimental 
design and clinic trial.  
Firstly, we employ the identifiable parameters from experimental observation to 
develop an integrated modeling methodology for microtubule dynamics and taxol 
kinetics, which can be applied to cancer therapy. We develop a hybrid model, including 
(1) a simple two-state stochastic formulation of tubulin polymerization kinetics and (2) an 
equilibrium approximation for the chemical kinetics of Taxol (paclitaxel) drug binding to 
microtubule ends. Model parameters are biologically realistic, with values taken directly 
from experimental measurements. Model validation is conducted against published 
experimental data comparing optical measurements of microtubule dynamics in cultured 
cells under normal and Taxol-treated conditions. This model is then used to quantitatively 
analyze the dynamic instability of microtubules, which can be applied in the future to 
better understanding the effects of microtubule-targeting cancer therapies (such as Taxol) 
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on cell cytoskeleton dynamics. Secondly, we develop a comprehensive quantitative 
biological system modeling to interpret flow cytometric data. This project shows the 
importance of a data-driven model of the changes in phenotypic variables upon 
perturbations to characterize the relative role of system components. There are two parts 
of this project. Firstly, we develop a phonotype experimental model of cell response on 
cell death stimulated by the mitochondrial uncoupler. We designed innovative protocols, 
assay technologies, and data analysis techniques to obtain plausible Flow Cytometry data. 
Secondly, we develop a ‘data-driven’ mathematical model to evaluate the effects of 
antioxidant N-acetylcysteine (NAC) on cell death. Our model quantifies the relative roles 
played by cell components and distinguishes between different biological hypotheses for 
how cell death stimulated by various agents. The validation of our modeling 
methodology shows consistency with publication. We further extended the modeling 
methodology we developed to other data sets collected from our laboratory and 
previously published data sets. This supports the extension of our modeling methodology 
to diverse biological problems in with varied data types, such as protein expression 
levels, phenotypic measurement, and gene expression data. The flexibility of the 
data-driven modeling approach makes it suitable for the broad landscape of biological 
research, even when little information is known about the structure of pathways, thus 
making it impossible to apply bottom-up mechanistic models. 
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CHAPTER 2: INTEGRATED MODELING 
METHODOLOGY FOR MICROTUBULE DYNAMICS 
AND TAXOL KINETICS WITH EXPERIMENTALLY 
IDENTIFIABLE PARAMETERS 
 
Note: This chapter is adapted from: H. Zhao, B. A. Sokhansanj. “Integrated modeling 
methodology for microtubule dynamics and Taxol kinetics with experimentally 
identifiable parameters,” Computer Methods & Programs in Biomedicine. 88(1): 
18-25, Oct. 2007. 
 
 
 
2.1 Summary 
Recent experimental evidence has shown that cigarette smoke metal-catalyzed oxidation 
of tubulin causes microtubule depolymerization. The change in cytoskeletal structure 
causes changes to cell function, exacerbating tissue malfunction in inflammatory 
diseases. Microtubule dynamics play a critical role in cell function and stress response, 
modulating mitosis, morphology, signaling, and transport. Drugs such as paclitaxel 
(Taxol) can impact tubulin polymerization and affect microtubule dynamics. To 
understand how stochastic damage at the microscale level can translate to global 
properties of cell transport and organization, we have developed an integrated mesoscale 
model of individual microtubule (MT) dynamics and simulated the effect of microtubule 
stabilizing drug (taxol) to predict and overall dynamics of the cytoskeleton.  
There has been significant interest in developing mathematical models for the 
complex processes of microtubule dynamics. Various models were developed on 
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microtubule dynamic instability and applied on mitosis. Regardless of how creative, 
innovative, and elegant their models and algorithms, the lack of experimental validation 
limits their predictions. In order to solve this problem, we develop the models with 
parameters based on realistic experimental observations with a clear quantitative sense of 
the accuracy of the predictions.  
While theoretical methods have been previously proposed to simulate microtubule 
dynamics, we develop a methodology here that can be used to compare model predictions 
with experimental data. Our model is a hybrid of (1) a simple two-state stochastic 
formulation of tubulin polymerization kinetics and (2) an equilibrium approximation for 
the chemical kinetics of Taxol drug binding to microtubule ends. Model parameters are 
biologically realistic, with values taken directly from experimental measurements. Model 
validation is conducted against published experimental data comparing optical 
measurements of microtubule dynamics under normal and Taxol-treated conditions. To 
compare model predictions with experimental data requires applying a “windowing” 
strategy on the spatiotemporal resolution of the simulation. From a biological 
perspective, this is consistent with interpreting the microtubule “pause” phenomenon at 
least partially the result of spatiotemporal resolution limits on experimental measurement 
rather than tubulin biochemistry. 
 
2.2 Introduction 
Microtubules are characterized by “dynamic instability”, stochastic cycling between 
growth (sometimes known as “rescue”) and shrinking (“catastrophe”) phases [15-17]. 
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This instability is critical for dynamic adjustments in accomplishing the cellular function 
of microtubules in mitosis, transport, and morphological changes [18-21]. Microtubules 
are key targets for improved cancer therapy (reviewed in [22]). The therapeutic targeting 
of microtubules affects mitosis and cell migration, as well as for their role in intracellular 
trafficking and cell signaling [23, 24].  Paclitaxel, known commonly by its trade name 
Taxol, is a prominent cancer therapeutic targeting microtubules [25]. Taxol binds 
microtubule subunits reversibly to regulate dynamic instability, disrupting mitosis and 
potentially altering cell signaling. Another important role for Taxol is in cell biology 
experiments, where it is used to inhibit microtubule dynamics to study the potential role 
of microtubules in the process under study [23, 24, 26]. 
There has been significant interest in developing mathematical models for the 
complex processes of microtubule dynamics. Hill proposed an early model based on 
kinetics of state changes at the microtubule end (growth and shrinking) with a focus on 
understanding the basics of dynamic instability [27]. Models have been developed for 
microtubules based on classical chemical kinetics of tubulin binding, for example with a 
focus on microtubule oscillations generated by dynamic instability [28]. Other modeling 
work has focused on mechanochemical aspects at the macromolecular scale [29]. A 
common approach for that are lattice-based simulations of microtubule growth and decay 
(reviewed in  [30]). Another methodology applies stochastic dynamical models of the 
unstable transition between growth and shrinking, developing a master equation and 
solving it with a mean field approximation. This approach was used in [31] to estimate 
the distribution of microtubule cap lengths and catastrophe length. Most of these models 
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have been developed to learn more about the basic science of microtubules themselves, as 
opposed to analyzing their role in the context of the cell. For example, Gliksman, et al. 
[32] use the stochastic dynamics approach to modeling microtubules in cell interphase 
dynamics. In that work, simulation results were interpreted purely theoretically; 
moreover, there was no way to include alterations in microtubule dynamics by Taxol. 
Several applied microtubule models have been developed for mitosis [33], but their 
model parameters and predictions do not quantitatively translate to experimental 
measurements of dynamics that are usable for cell signaling or trafficking functions. 
There has also been recent theoretical work on models of microtubule dynamics that 
include the effect of catastrophe-suppressing drugs (such as Taxol); however, it includes 
a large number of parameters and cannot be readily integrated with experimental 
observations [34]. 
Our objective is to develop a realistic model of microtubule dynamics that is 
applicable to their role in overall cell function. We develop an integrated model that 
combines a well-established methodology for microtubule dynamics with a model for the 
binding of Taxol and suppression of tubulin polymerization, using parameters that have 
an explicit experimental interpretation. A key component of our modeling methodology 
is imposing artificial spatiotemporal resolution limits to transform simulation results, 
allowing for quantitative comparison with experimental data from microscopic 
visualization of microtubule dynamics. 
 
2.3 Methods 
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2.3.1 Overview 
We construct a modular, hybrid multiscale model to describe the effect of Taxol 
interaction with microtubules on microtubule dynamic instability. The model is designed 
such that all parameters are realistic, such that they can be explicitly identified with a 
biologically relevant and experimentally measurable property of the system. 
Consequently, parameter values are taken directly from measured data. We make no 
assumptions nor fit parameters to data. 
The modeling methodology is fundamentally probabilistic. Each microtubule is 
simulated independently. At fixed time steps separated by intervals of Dt, probabilities 
are calculated using state equations (presented below) for (a) the binding of Taxol to 
microtubule ends and (b) the growing or shrinking / pausing state of the microtubule. The 
microtubule can shrink if Taxol is not bound, it can pause if Taxol is bound, and it has a 
probability of growing in both cases. The length of the microtubule changes by an 
interval Dx that depends on the speed of the microtubule (v+, v-, or 0, for growing, 
shrinking, and pausing respectively) assumed to be an empirical constant. 
We have implemented the model to simulate any number of microtubules within 
Matlab 7.0 R14 (The Mathworks, Inc., Natick, MA, USA).  
 
2.3.2 Theoretical Model of Dynamic Instability 
We base our module for simulating microtubule dynamics on the theoretical model for 
microtubule dynamic instability introduced in Dogterom and Leibler [25]. In their model, 
rigid microtubules grow perpendicularly from a nucleation site (near the nucleus) defined 
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as the minus end, heading (at the plus end) to the membrane with random orientation. 
Each microtubule randomly switches between polymerization (“growth” or “rescue”) and 
depolymerization (“shrinking” or “catastrophe”) states. It has been suggested [35] that 
there is also a meta-stable pause state, but it does not have to be included in the model to 
predict dynamic instability. When microtubules touch the membrane, they randomly 
shrink or stop (in our work, if a limit is imposed, it is typically set at 12.5 mm). When the 
microtubules shrink back to the nucleation site, they randomly either grow again or stop. 
In this model, the minus ends are assumed to be static, which is relevant for many but not 
all cellular function considerations (an exception is reviewed in [36]). 
Equation 1 is the master equation for the two-state model, for the time dependent 
probability that a microtubule will grow (p+) or shrink (p-) where Ksg and Kgs are 
transition rates from the shrinking to growth and vice versa states respectively. 
 
∂p+
∂t = Ksg p− − Kgs p+ − vg
∂p+
∂l
∂p−
∂t = −Ksg p− + Kgs p+ + vs
∂p−
∂l
           (1) 
 
In our simulations based on experimental data, we use Kgs and Ksg respectively are 
obtained from reported observed frequencies of catastrophe (shrinking) and rescue 
(growth), which are typically calculated using the method described in [25]. 
 
2.3.3 Microtubule Dynamics in the Presence of Taxol 
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In principle, Taxol is observed to prevent or dramatically reduce microtubule shrinking. 
Based on biochemical evidence [37], any microtubule disassembly (shrinking) that does 
occur in the presence of sufficient Taxol is due to its dissociation from the microtubule 
end, which allows the dissociation of the tubulin subunit. Therefore, when Taxol is bound 
to a microtubule end, we assume that there is no shrinking of the microtubule, though 
growth can continue. Based on this assumption, Taxol-bound microtubule dynamics 
follow Equation 2. The shrinking state of Equation 1 is replaced by a pause state, thus the 
two probabilities that are calculated here are p0 (pause) and p+ (growth). The transition 
rates are labeled K0g and Kg0. 
∂p+
∂t = K0g p0 − Kg 0 p+ − vg
∂p+
∂l
∂p0
∂t = −K0g p0 + Kg 0 p+
            (2) 
In our simulations, we make the physically motivated assumption [38] that Taxol 
does not change the probability of growth at the microtubule end (K0g = Ksg). We assume 
that Taxol binding simply prevents tubulin detachment from the end, thus preventing 
shrinking and resulting in a pause instead (Kg0 = Kgs). 
 
2.3.4 Taxol-Microtubule Interaction 
At each time step of the simulation, it is necessary to determine for each microtubule 
whether to use Equation 1 or 2, and thus whether the random number selected at that 
point choose whether to (Equation 1, Taxol not bound) grow or shrink or (Equation 2, 
Taxol bound) grow or pause. Thus, for at each microtubule at each time point, we 
determine a probability that Taxol is bound at its end. Then, using a random 
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determination based on that probability, either Equation 1 or 2 is used to generate a 
second random number to determine the microtubule length change. We employ a model 
for Taxol-microtubule binding based on chemical kinetics. Our first assumption is that 
Taxol does not bind to free tubulin at significant levels, based on in vitro [38] and in vivo 
[39] evidence. Thus, we model the binding of Taxol to binding sites within microtubules 
(MTbindingsite) as a reversible reaction: 
TaxolMTMTTaxol ebindingsit .⇔+           (3) 
Notably, microtubule binding sites may be either in the interior of the microtubule or 
the ends, and it is in the latter case where the binding of Taxol has a functional impact on 
microtubule dynamics. We assume that the reaction in Equation 3 reaches equilibrium 
quickly, on a time scale much smaller than the time interval Dt of the microtubule 
dynamics simulation. This is supported by experimental evidence for rapid binding of 
Taxol to microtubules [40]. We define the following system (Equations 4-7) based on the 
rapid equilibrium assumption to determine the probability (PMTbound) that the end of the 
microtubule is bound (leading to the use of Equation 2 instead of Equation 1). 
[ ] [ ]
[ ]boundend
freefreeend
d MT
TaxolMT
K
×=             (4) 
[ ] [ ]
[ ]
boundesbindingsit
freefreeesbindingsit
d MT
TaxolMT
K
×
=           
 (5) 
[ ] [ ] [ ]
boundesbindingsitboundendbound
MTMTTaxol +=        (6) 
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[ ]
[ ]totalend
boundend
MTbound MT
MT
P =              (7) 
In the absence of biochemical evidence to the contrary, Equations 4-5 assume that 
the dissociation of Taxol from microtubule ends (MTend) is equal to that from binding 
sites in the interior of microtubules (MTbindingsites). Our model also assumes that the total 
free and bound Taxol concentration remains constant over time, and that free Taxol 
concentration is in excess, thus, 
[ ] [ ] [ ]boundfreefree TaxolTaxolTaxol −≈          (8) 
In reality, dosing, pumping, and possibly sequestration of free Taxol can occur. 
Given the structure of our simple time-stepping stochastic simulation, we can easily relax 
this assumption in a modular way by adding additional equations to update the free Taxol 
concentration over each time interval Dt. 
With our assumptions, solving this system requires two parameters. The 
concentration of Taxol available for binding ([Taxol]free) is determined for the particular 
experimental conditions being simulated, typically as the dose given to the cell (or 
measured as the intracellular Taxol concentration). The other key parameter is the 
Taxol-microtubule equilibrium dissociation constant Kd. The Kd we used was 500 nM, 
based on reported values of 100-1000 nM [37] as referred to in [41], and the original 
citation giving Taxol-microtubule binding kinetics in vitro [38]. This measurement is also 
supported by in vivo results on microtubule binding kinetics within the cell [39]. 
 
2.4 Results and Analysis 
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2.4.1 Qualitative Results 
Figure 2.1a shows a demonstration of the hybrid simulation of the dynamics of a single 
microtubule. The result represents a single Monte Carlo run, i.e., sequence of random 
numbers, for each of the Taxol-treated and untreated cases. The simulated “life history” 
plot is launched from an initial microtubule length that is the same as one taken from in 
vivo microscopy data for the A-498 human cell line reported in [41]. The frequency of 
shrinking (catastrophe) and growing (rescue) transitions reported for multiple observed 
microtubules in [41] are used for Ksg and Kgs to solve Equation 1. Figure 2.1b shows the 
experimentally measured life history plot. As can be seen from comparing Figure 2.1a 
and 1b, simulations with Taxol treatment give qualitative results in line with those seen in 
experimental data: more small length changes between time points, and reduced 
catastrophe events and duration. 
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Figure 2.1 “Life history” plot of microtubule end position over time for a single 
microtubule from (a) simulated and (b) in vivo experimental data for the A-498 human 
cell line [41] under both untreated (solid line) and Taxol-treated (dashed line) conditions. 
(The experimental curves for Fig. 1b were obtained by manually tracing and interpolating 
graphical results reported in [41].) For the simulated data (Fig. 1a), we used a 100 nM 
dose of Taxol is used for total Taxol concentration ([Taxol]free) to solve Equations 4-7, 
consistent with the experiment [41]. Simulations were performed with a spatial resolution 
of 0.0003 mm and temporal resolution of 0.2 s. 
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2.4.2 Quantitative Comparison of Simulated and Experimental Results 
Our goal is to develop a modeling methodology that allows seamlessly transitions 
between simulation and experiment to identify parameters and interpret results. 
Experimental data for in vivo microtubule dynamics are typically (e.g., [41, 42]) obtained 
by tracking individual fluorescently labeled (i.e., by incorporating GFP-tubulin) 
microtubules and calculating parameters for “microtubule dynamicity”. These include, 
for example, growth and shrinking lengths, which represent the gross total length change 
while the microtubule is growing and shrinking over the course of simulation. Other key 
parameters are the amounts of time a microtubule spends growing, shrinking, and 
remaining stable (“paused”) in its life history plot, generally as a fraction of the total 
observation time. We would like to compare our simulated predictions of these 
parameters with experimental data. As this study shows, we have found that the key issue 
is that simulations can generate results with arbitrarily small Dx and Dt resolutions. On 
the other hand, video analysis of microtubules in living cells is limited by the spatial 
resolution of the image and the time interval of slide capture.  
To analyze our modeling methodology, we compared our simulation results with the 
microtubule dynamicity parameters measured for the effect of Taxol treatment A498 
human kidney tumor cells by Yvon, et al. [41]. Our goal was to obtain accurate 
comparison with quantitative data, specifically for the experimentally observed changes 
in microtubule dynamics observed upon treatment with Taxol. Experimental data were 
acquired by measuring individual microtubules tracked in time lapse video images, with 
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spatial resolution of 0.5 mm and temporal resolution of 2 s. Simulations were performed 
with a spatial resolution of 0.002 mm (Dx) and temporal resolution of 0.2 s (Dt). 
To address the difference in resolution between simulated and real data, we 
considered the effect of “windowing” simulated data by the experimental measurement 
resolution. Without windows, any increase or decrease of microtubule length in the 
simulation counts as a growth or shrinkage event. With windows, a net change of 0.5 mm 
(effectively 250Dx) over 0.2 s (10Dt) defines a growth or shrinkage event. Any smaller 
variations that add up to less of a net change are interpreted as a pause. This follows the 
procedure used to generate dynamicity parameters from the experimental data. 
The key microtubule dynamicity parameters reported by Yvon, et al. [41] were 
estimated, simulating individual microtubules using Equations 1-7. Results were 
averaged over the same number of microtubules as tracked in the experiments: 40 under 
control conditions and 26 with Taxol treatment. As with the experiment, the duration of 
the simulation was 120 s. The total concentration of Taxol was kept as a constant 17.4 
mM, in the simulation. This was the intracellular taxol concentration measured by the 
authors after culturing the cells with 100 nM dosage. Table 2.1 summarizes the results of 
our simulations with and without the application of “windows” of 0.5 mm and 2 s to 
estimate parameters. There is a pronounced reduction in growing and shrinking events 
upon applying the measurement windows, as expected. Notably, with the windows, Taxol 
treatment results in a much larger change in predicted parameters for microtubule 
dynamics. As shown in Table 2.2, these predicted changes in microtubule dynamics upon 
Taxol treatment are consistent with experimental data. 
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Table 2.1 Estimated Microtubule Dynamicity Parameters for A-498 Cells 
  Growth 
Length 
(mm) 
Shrinking
Length 
(mm) 
Growth 
Duration 
(% total) 
Shrinking 
Duration 
(% total) 
Pause 
Duration
(% total) 
 with Untreated 2.66 2.78 19.0 19.8 61.2 
windowing Taxol 1.60 1.65 11.4 11.8 76.8 
without Untreated 4.93 4.93 58.9 41.1 * 
windowing Taxol 4.22 4.22 50.5 35.2 14.3 
* No pausing is possible for simulation results without windows. 
 
 
 
 
Table 2.2 Simulated and Published Data for the Effect of Taxol (A-498 cell line) 
 Growth 
Length 
Shrinking 
Length 
Growth 
Duration 
Shrinking 
Duration 
Pause 
Duration 
Literature -34.5% -26.8% -42.9% -52.9% 31.1%
Windows -40.0% -40.4% -40.1% -40.4% 25.6%
  No 
Windows -14.3% -14.4% -14.3% -14.5% n/d 
 
 
  
For additional model validation, we also analyzed results for the other cells measured 
in [41], the Caov-3 human colorectal carcinoma cell line. In this case, the Taxol dosage 
was 30 nM, with 36 microtubules tracked in the absence of Taxol and 34 with Taxol. 
Table 2.3 shows the published results as compared with the simulation using the 0.5 mm 
and 2 s windows to compute dynamicity parameters as described above. The model 
estimates for the change of microtubule dynamics upon Taxol treatment are 
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quantitatively consistent with experimental measurements (noting the large variance that 
was reported). 
 
 
 
Table 2.3 Simulated and Published Data for the Effect of Taxol (Caov-3 cell line) 
  Growth 
Length 
(mm) 
Shrinking
Length 
(mm) 
Growth 
Duration
(% total) 
Shrinking 
Duration 
(% total) 
Pause 
Duration
(% total) 
Literature Untreated 1.23 ± 1.1 1.41 ± 1.0 23.9 13.2 62.9 
 Taxol 0.97±0.65 1.18 ± 1.2 19.5 13.8 66.7 
 %Change -21.1% -16.3% -18.4% 4.5% 6.0% 
Simulation Untreated 2.69 2.35 19.3 16.8 64.0 
 Taxol 2.27 2.31 16.2 16.5 67.3 
 %Change -15.8% -1.7% -15.9% -1.7% 5.2% 
 
 
 
2.4.3 Stability Analysis of Simulation Parameters 
Simulation convergence is an important issue for the finite step-size simulation of 
stochastic processes (Equations 1 and 2). In our investigation, we found no pathological 
effects due to varying Dx and Dt. Figure 2.2 a-c show simulated life-history plots 
(determined as for Figure 2.1) for simulation time intervals of 2, 0.2, and 0.02 seconds. 
These simulations show how the random variation between simulated microtubule 
dynamics in different random runs decrease as the time interval decreases. However, the 
overall average does not change, thus the simulations are generally robust to Dt. (We 
typically 0.2 s for our simulations as a compromise between minimizing processing time 
and error.) 
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Figure 2.2 Life-history plots of microtubule end position (mm) as a function of time 
(s) over 60 seconds for simulated individual microtubules, using the same parameters as 
in Figure 2.1. Plots (a)-(c) show simulations using time intervals (Dt) of 2, 0.2, and 0.02 
seconds respectively. Curves of different colors and patterns represent different runs of 
the simulation (i.e., for different random number generator seeds). 
 
 
 
We did find sensitivity to initial parameters of the simulation. Figure 2.3 shows an 
example of dependence on the initial growth probability p+(0) (in Equations 1 and 2). 
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This is a relevant initial condition because in our simulations we did not consider 
probabilistic nucleation. Nucleation is the initiation of a new microtubules, which is 
followed by p+(0) = 1 and p-(0) = 0. Including this would complicate our Taxol binding 
model and has been left for the future. As shown in Figure 2.3, we found that the 
sensitivity to initial conditions of the estimated microtubule dynamics from simulation 
(such as the growth length quoted in Table 2.1) dies off with increasing simulation time. 
Notably, in our simulations, we typically found that after 14 s of the taxol concentration 
the Taxol concentration reached steady state (allowing us to use the assumption of 
Equation 8). Thus for all of our calculations we consider the final 120 s of a 1200 s 
simulation. This is actually consistent with how experimental data are acquired and 
interpreted. Microtubules tracked on video have generally already grown to a fairly 
significant length (as can be observed directly in similar time lapse videos available as 
online supplements, e.g., [43]). Also, Taxol treatments in experiments, such as those 
analyzed in this work, are performed well in advance of data acquisition and cells reach a 
steady state of intracellular Taxol concentration [41].  
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Figure 2.3 Dependence of simualted average microtubule growth length on initial 
growth probability condition p+(t = 0). The simulation was run as for experimental 
conditions for A549 cells (as reported in Table 1) without adding Taxol. (Results were 
similar with the addition of Taxol). The plot shows the first 60 seconds of the simulation 
(solid line) and last 60 seconds (dashed line) of a 1200 second simulation. 
 
 
 
2.5 Discussion and Conclusions 
An experimentally realistic and computationally tractable model for microtubule 
dynamics in the cell such as we present here is a necessary component for integrated, 
multiscale modeling of the cell. Mathematical models are increasingly significant tools 
for integrating knowledge, developing hypotheses, and designing experiments for the 
complex problems of cell biology. Tools have been developed for modeling 
spatiotemporal cell dynamics (e.g., [44]) and there have been several approaches applied 
to the problem of cell signaling (as reviewed in [45]). It is critically important have the 
ability to go back and forth between experiments and models [46]. 
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The integrated hybrid model presented here for microtubule dynamics and Taxol 
kinetics is modular and can be included in modular multiscale spatiotemporal models of 
cell biology. Simulations of microtubule dynamics using the model generate qualitative 
and quantitative predictions that are comparable with experimental data. Quantitative 
simulations are based on a limited number of free parameters, which are directly 
identifiable from experimental measurements without any fitting. Simulated results are 
quantitatively consistent with experimental data for the impact of Taxol treatment on the 
dynamics of microtubule length change in living human cells. The model is limited in its 
ability to handle transients in system change, such as the response to Taxol treatment. It 
is necessary to assume a steady state prior to applying the model because of the 
equilibrium assumptions for chemical kinetics. However, based on our analysis the 
relaxation time is consistent with the time used in experiments to allow the system to 
reach a steady state. 
The core of the modeling scheme depends on a simple alternating two-state scheme 
for microtubule dynamics: growing and shrinking only in the absence of Taxol (Equation 
1) and only growing and pausing when Taxol is bound to the microtubule end (Equation 
2). In the absence of Taxol, Equation 1 cannot replicate experimental observations of 
microtubule pausing. This changes once we consider the experimentally realistic situation 
of a measurement “window”, a time and space interval corresponding to the resolution of 
video microscopy data. In this case, not only is there pause behavior, but the simulated 
results comparing Taxol and untreated cases are found in our analysis to be consistent 
with a published experimental data set. 
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Our results suggest two biologically relevant interpretations. (1) Microtubule length 
decreases in the presence of Taxol can be accounted for entirely by the stochastic nature 
of Taxol binding to microtubule ends. (2) No explicit treatment of a pause state in normal 
microtubule dynamics is necessary to explain experimental results, which can be 
accounted for entirely by the limited resolution of experimental methodology and 
instrumentation. These are, however, theoretical interpretations. Without further 
experiments, we cannot preclude the possibility that Taxol-bound microtubule ends can 
shrink and a dynamic pause state does exist in vivo. However, in support of our 
interpretation, pauses are observed in the context of cells in vivo [42, 47, 48], but little 
pausing is observed in biochemical measurements in vitro [49]. 
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CHAPTER 3:  QUANTITATIVE BIOLOGICAL 
SYSTEM MODELING OF OXIDATIVE STRESS AND 
CELL DEATH BASED ON FLOW CYTOMETRIC DATA 
 
Note: This chapter is adapted from a paper submitted to Theoretical Biology and 
Medical Modeling that is currently under review. 
 
 
 
3.1 Summary 
As described in Chapter 1, we develop our methods with a focus on biological problems 
related to the role of ROS in regulating cell death. This is because of its potentially 
significant impact on driving inflammatory pathways and thus affecting the progress of 
many human diseases. In this chapter, we begin to develop modeling methods in 
experimental design and model identification. Mathematical models rigorously integrate 
information about the behavior of a complex system. Validated quantitative models of 
cell functions can be used to predict and understand the effect of novel therapeutic 
combinations on cells, interpret multiplexed diagnostic biomarkers, and predict cellular 
consequences of genome variation. Developing accurate system models depends on 
obtaining accurate parameter values based on experimental data. In the work described in 
this chapter, we sought to develop an integrated modeling and experimental validation 
methodology that could account for issues of experimental noise, poor reproducibility, 
and limited data set size that are typical in biological systems analysis problems.  
We used cell population-based flow cytometry data to select a quantitative system 
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model and perform parameter estimation for a specific test case: the role of intracellular 
reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) in Jurkat T 
lymphocyte death induced by CCCP (carbonyl cyanide m-chlorophenylhydrazone), a 
strong mitochondrial uncoupler. Two independent “training” and “test” time series were 
obtained for ROS, MMP, and cell viability through flow cytometry experiments. 
Nonlinear parameter estimation was performed on each data set, and parameters and 
predictions were compared between them to evaluate model robustness.  
CCCP was found to directly lead to Jurkat cell death, accompanied by increased 
ROS and mitochondrial membrane permeability. We used parameter sensitivity analysis 
to assess the model robustness and simplify model equations. Our analysis robustly 
showed ROS mediated CCCP effects fit data better than those assuming direct mediation 
by MMP depolarization. This is consistent with additional experimental results showing 
that antioxidant N-acetylcysteine (NAC) inhibited the effects of CCCP on ROS and cell 
death.  
The modeling and validation methodology allowed for quantitative definition of the 
complex time-dependent impact of CCCP on cell phenotype. This approach can be 
generalized to quantitatively test hypotheses on other kinds of measurements of multiple 
intracellular fluorescent markers within practical limits on data set size and quality. 
 
3.2 Background and Literature Survey 
3.2.1 Overview of the Complex Roles of ROS in Cell Death 
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It has been wildly reported that oxidative stress elicits a wide spectrum of cellular 
responses ranging from proliferation to growth arrest, to senescence, to cell death. The 
overabundant generation of ROS in a system during infection response causes cell 
damage. Stressors include respiratory burst, generating superoxide (O2-) which is 
converted to hydrogen peroxide (H2O2), leading to hydroxyl radical (OH) production 
[50]. It is known that ROS affects cell behavior in many ways. Figure 3.1 shows 
pathways by which ROS triggers cell death. The levels of ROS, which determine cells 
undergoing proliferation, apoptosis, or any other events, are cell-type-specific [51]. 
 
 
 
 
Figure 3.1 Shown here is a scheme based on current knowledge about the role of 
ROS-induced cell death in stimulating inflammation.  
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3.2.2 Mitochondrial Membrane Potential (MMP) and Cell Death under Oxidative 
Stress Induced by the Uncoupler of Oxidative Phosphorylation 
Mitochondria are key sites where cell stress responses are integrated and trigger cell 
death pathways, especially play a pivotal role in the intrinsic pathway of apoptosis. ROS 
generated by mitochondrial respiration can be enhanced under oxidative stress [52] and 
as a result of electron transport chain (ETC) defects [53, 54]. The phenomenon of ROS 
induced apoptotic cell death are associated with Bax/Bad mitochondrial translocation, 
upregulation of P53, loss of ψm, mitochondrial Cyt-c release, caspase-3 activation, PARP 
cleavage, and DNA fragmentation [55].  
The electrons flow along ETC, shown in Figure 3.2. In the mitochondrial matrix 
side, the electrons flow down their chemical gradient, and pump protons from the 
mitochondrial matrix to the innermembrane space, against their electrochemical gradient. 
This proton pumping consists an electrical gradient (i.e. membrane potential), which is 
accompanied by a small chemical gradient (i.e. pH difference). Additionally, the 
protonmotive force is generated due to this active proton pumping, and drives protons 
back into the matrix, resulting in ATP synthesis [56].  Shown in Figure 3.2, the upper 
circuit describes the process of intracellular respiration, and the lower circuit shows the 
process of mitochondrial membrane oxidative phosphorylation.  
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Figure 3.2 The chemiosmotic proton circuit in the mitochondrial inner membrane 
[52]. 
 
 
 
Carbonyl cyanide m-chlorophenylhydrazone (CCCP) is a strong uncoupler of 
oxidative phosphorylation. It renders the mitochondrial inner membrane permeable for 
protons and causes dissipation of the proton gradient across the inner mitochondrial 
membrane, and results in protons leaking and a rapid reduction in MMP [52]. The proton 
leak induced by CCCP imposes ATP and ROS production. Previous studies identify a 
complex cell type dependent role for CCCP in inducing cell death.  
 
3.2.3 Antioxidant Efficacy of N-acetylcysteine (NAC) 
NAC is a thiol compound that acts as a precursor for reduced glutathione (GSH) altering 
the intracellular redox potential. In a mediate dose of NAC, it increases the synthesis of 
GSH, which can effectively reduce ROS. NAC also functions as a direct scavenger of 
free radicals by donating sulfhydryl (SH) group [57].  Additionally, NAC regulates 
multiple key proteins in cell signaling pathways in inflammation. It modulates these 
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inflammatory pathways by adjusting intracellular ROS levels. NAC has reported 
inhibition effect on NFκB activation at a certain dose. Because of the multiple roles of 
NAC, dose optimization of NAC is a challenge in both in vivo and in vitro experiments.  
 
3.2.4 Significance of Quantitative Biological System Modeling 
Molecular biology experiments have conventionally emphasized descriptive, qualitative 
outcomes. For example, the absolute knockout of a protein may be said to result in a 
statistically significant “increase” in apoptosis. In many cases, absent is a measure of the 
degree of the observed effect, i.e., the kind of quantitative data that is typically obtained 
in a chemical or physical experiment. The construction of engineering models of physical 
and chemical systems requires parameters that are quantitative in nature that describe the 
system. Similarly, developing system models at the cellular and molecular pathway level 
will also require characterizing biological phenomena with quantitative measurements. 
This may be important to identify genetic variants associated with a quantitative increase 
in disease susceptibility. If the genetic variant leads to a quantitative decline a protein’s 
function – say 10% rather than the absolute 100% of a non-functional mutant or 
experimental knockout – then the impact on cell phenotype that leads to the disease will 
be similarly quantitative. It is also important to characterize these quantitative variants in 
pharmacogenomics, the design of complex therapeutic strategies to target individual 
variability in how cells function. 
However, there are significant challenges in employing the conventional modeling 
methodology used in engineering and physical sciences to biological system analysis 
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problems.  
In particular, there are often few data points, due to the cost of biological materials 
and the time required to perform experiments. Often, non-destructive experiments are 
impossible, so each data point in a time series represents an independent experiment. One 
of the most convenient methods (and sometimes the only one practical) for measuring 
biological data is through the use of fluorescent markers in microscopy or flow 
cytometry. Unfortunately, these data lack units. While it may be possible to calibrate 
measurements of protein level, that is difficult, unreliable, and impossible for other kinds 
of fluorescent measurements, including those used in this study. 
In this project, we describe and implement a methodology to generate quantitative 
information for cell phenotype in response to stress by using a mathematical model to 
analyze experimental data. Our goal is to demonstrate the use of an ordinary differential 
equation (ODE) system model to interpret typical, noisy biological data using nonlinear 
parameter estimation, describing both the strengths and limitations of the approach on a 
specific example with multiple phenotypic variables. We integrate the modeling and 
experimental validation procedure, and we use multiple analyses to validate parameter 
estimates and simplify the model structure. 
The specific problem we focus on is the effect on Jurkat lymphocyte survival of 
carbonyl cyanide m-chlorophenylhydrazone (CCCP), a strong uncoupler of oxidative 
phosphorylation which induces a rapid reduction in mitochondrial membrane potential 
(MMP) [58]. We apply nonlinear parameter estimation to models based on flow 
cytometry data. The results are used to analyze the relative roles of mitochondrial 
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membrane depolarization and intracellular ROS increase in the process of CCCP-induced 
Jurkat lymphocyte death. 
This biological problem arises from previous studies identifying a complex and 
potentially cell type-dependent role for CCCP in inducing apoptosis. These results 
include reports of apoptosis in Jurkat lymphocyte [59] and HL-60 cell lines [60], 
conflicting with another study in Jurkat cells suggesting that CCCP only enhanced 
apoptosis but did not cause it on its own [61]. In line with the latter result, CCCP was 
found not to induce apoptosis in colon carcinoma [62] and osteosarcoma cells [63] unless 
co-treated with another agent. Notably, in these studies Bcl-2 overexpression was shown 
to have largely blocked cytochrome c release and apoptosis, without affecting 
mitochondrial depolarization by CCCP, suggesting that CCCP induction of apoptosis and 
mitochondrial depolarization can be disconnected activities. Additional evidence for 
CCCP potentiating apoptosis by TRAIL (tumor necrosis factor-related 
apoptosis-inducing ligand) in TRAIL-resistant colon carcinoma cell lines suggested that 
the effect of CCCP is mediated by increasing ROS rather than its reduction of MMP 
leading directly to Bax translocation and cytochrome c release [62, 64]. In this paper, we 
test the two hypotheses that CCCP-induced cell death occurs through the ROS or MMP 
pathways. To this end, we developed mathematical models of the alternative ROS- and 
MMP-mediated scenarios and generated flow cytometry data to evaluate them. 
  
3.3 Methods 
3.3.1 Materials 
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Human Jurkat leukemic T lymphocyte cells (Clone E6-1) were obtained from the 
American Type Culture Collection (TIB-152; Manassas, VA). Media and fetal bovine 
serum (FBS) were obtained from Mediatech (Herndon, VA). CCCP and 
5-(and-6)-carboxy-2’,7’-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) were 
obtained from Invitrogen (Eugene, OR). N-acetylcysteine (NAC) was obtained from 
EMD Calbiochem (Gibbstown, NJ).  
 
3.3.2 Cell Culture and Treatments 
Human T-leukemic Jurkat cells (ATCC, Manassas, VA) were maintained in RPMI-1640 
medium containing 10 mM Hepes, 1 mM sodium pyruvate, 2 mM L-glutamine, 4.5 g/L 
glucose, and 10% FBS (Mediatech, Herndon, VA), and incubated at 37 ºC and under 
atmosphere of 95% O2 and 5% CO2. Jurkat cells were seeded at 5 × 105 cells/mL (with 
viability > 90% verified by trypan blue exclusion method) and treated in pre-warmed 
media in T25 cell culture flasks. Treatments were mixed into fresh media before adding 
to cells. Treatments were 50 µM CCCP and 1mM NAC for the indicated treatment 
durations. The CCCP dose was selected based on preliminary experiments for maximum 
mitochondrial dye response without decreasing cell viability at 2 h, which suggested the 
potential for non-apoptotic toxicity of a higher dose. The appropriate NAC concentration 
was to achieve minimum toxicity and maximum ROS suppression (based on flow 
cytometry data not shown here). NAC was added 2 h prior to CCCP treatment, and also 
mixed with CCCP into fresh media for the indicated time. Untreated cells were cultured 
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in media at the volume added for the treatments. All experiments were performed in 
triplicate. 
 
3.3.3 Data Collection by Flow Cytometry  
After treatments, cells were harvested to 1 mL volumes with between 0.5-1.5 × 106 
cells/mL and suspended in PBS without Ca or Mg ions. For ROS detection, cells were 
incubated with 5-(and-6)-carboxy-2’, 7’-dichlorodihydrofluorescein diacetate 
(carboxy-H2DCFDA; Molecular Probes) at a concentration of 5 µL/mL of a stock 
solution at 0.24 mg/mL. MMP was assayed by tetramethylrhodamine ethyl ester (TMRE; 
Trevigen, Gaithersburg, MD; as a constituent in the “Mitoshift” assay kit) following the 
manufacturer’s protocol, with 0.1 µL/mL. ROS and MMP were assayed separately by 
incubating cells with carboxy-H2DCFDA and TMRE at 37 ºC at 95% O2 and 5% CO2 
for 50 min. and 30 min. respectively. 
Samples were analyzed on a FACSCanto flow cytometer (Becton Dickinson, San 
Jose, CA) equipped with a 20-mW 488 nm solid state laser. The green fluorescence (FL1; 
H2DCFDA) was collected through a 530/30 band pass filter, orange/red fluorescence was 
collected through a 585/42 band pass filter (FL2; TMRE). Data acquisition (minimum of 
3 × 104 events/sample) was performed using FACSDiva software. Photomultiplier tube 
voltage was set up in linear mode for forward (FSC) and side (SSC) light scatter and in 
logarithmic mode for fluorescence. Typically, FL1 and FL2 voltages were set up by 
analyzing cells stained singularly to determine saturation points (typical voltages were 
FSC = 35, SSC = 418, FL1 = 456 for ROS, and FL2 = 450 for MMP). Data were 
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processed using FACSDiva software for the selection of cell populations as described 
below. 
 
3.3.4 Quantification of Cell Populations for Cell Viability, ROS, and MMP 
We define viable cells using morphologically defined positions as indicated by the FSC 
versus SSC scatter plot shown in Figure 3.3a, showing populations that can be defined as 
[live cells] and [dead cells]. Figure 3.3b represents one example of extensive 
experimentation that showed that YOPRO-1 staining (as well as propidium iodide (PI) 
staining not shown) to identify dead and dying cells (as described in [65]) agrees with the 
FSC/SSC definition that we used in this paper, which is consistent with previous data on 
morphological (FSC/SSC) parameters found for apoptosis in Jurkat cells as [66]. 
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Figure 3.3 Example of population based on 1D and 2D histograms. (A) Definition of 
live and dead cells based on morphology (FSC vs. SSC as described in the Methods and 
Results). (B) The same populations shown as fractions of the histograms of the logarithm 
of the fluorescent intensity representing YOPRO-1 staining (30 min. incubation at 4°C, 
0.5 µL/mL in 500 mL PBS, FL1 channel described in the Methods).  Here shown is the 
definition of populations based on 1D histograms, indicating populations representing 
“dead” cells and “live” cells, which are computed for modeling as fractions of the total 
combined population of the two groups. Shown are data from CCCP treatment for 2 
hours. (C) and (D) Examples of [ROS low] / [ROS high] and [MMP+] / [MMP-] 
definitions respectively for a live cell population (drawn from the live cell population 
defined as in (A)). In this case, the grey histogram is for the live cells from an untreated 
cell sample, and the black histogram represents the cells from a cell sample treated with 
CCCP for 2 hours. 
 
 
 
Using the morphological definitions indicated by the example in Figure 3.3a, for the 
other two variables we gated for viable cells in FSC vs. SSC. Then, for the live cell 
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fraction, we defined cell populations using histograms as in Figure 3.3c to define cell 
population fractions by intracellular ROS level ([ROS high]) and ([ROS low]) based on 
the intensity of FL1, and as in Figure 3.3d for mitochondrial membrane potential 
([MMP-] and [MMP+]) based on the intensity of FL2, corresponding to mitochondrial 
dye (TMRE) permeability. We analyzed the full range of results from low to high 
intensity collected at various treatment time points and defining the low end and high 
ends as shown in Figures 3.3c and 3.3d.  The fractions were normalized in each case by 
dividing by the number of live cells from which they were drawn. 
ROS quantification was complicated by poor reproducibility due to high noise and 
background levels due to potential artifactual oxidation, which is a well-known problem 
with interpreting ROS through dye-based methods in flow cytometry [67]. While 
intra-sample variability was low, inter-sample variability was significant and almost 
entirely attributable to background level differences. Thus, we set the background [ROS 
high] level of each time series by subtracting the level used for the initial time (0 h), 
which is the average of the measurement for untreated cells at various time points. There 
is no subtraction between independent time series.  
The fluorescence response of the mitochondrial dye (TMRE) for staining 
mitochondria with intact membranes (i.e., untreated cells) increases linearly (no 
saturation) in its optimum dye concentrations (between 0.1 µL/mL to 1 µL/mL). 
However, when the membrane potential changes with CCCP treatment, there is saturation 
observed. Consequently, we linearly normalized [MMP-] by its maximum value to 
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increase the dynamic range of the measurement as a pre-processing step before modeling 
analysis. 
 
3.3.5 Caspase-3 Activity 
Caspase-3 activity was measured by the activity of cell extract in generating a 
fluorescence signal by the release of rhodamine 110 (R110) from the cleavage of a fused 
Asp-Glu-Val-Asp DEVD-R110 substrate. Substrates and other components were 
obtained from the EnzChek Caspase-3 Assay #2 (Molecular Probes), and the 
manufacturers protocol was employed. Assays were performed in triplicate in a 96-well 
plate, and fluorescence signal was measured using a Fluoroskan Ascent Fl (Thermo 
Labsystems, Helsinki, Finland) with peak excitation and emission wavelengths of 496 nm 
and 520 nm respectively. Fluorescence units were converted to R110 molarity using a 
standard curve generated with free R110, and samples without the DEVD-R110 subtrate 
were used to determine background. Measurements were made at multiple time points 
until a linear rate was obtained. Approximately 1 × 106 cells/mL were used, with 
absolute levels quantified by DNA detection as described. 
 
3.3.6 ATP assay 
Intracellular ATP content was quantified by the activity of recombinant firefly luciferase 
in the ATP-dependent reaction with a D-luciferin substrate (Invitrogen). ATP was 
released from the the cell membrane using the FL-SAR somatic cell ATP releasing 
reagent (Sigma-Aldrich, St. Louis, MO). Luminescence was measured by the Top Count 
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NXT Microplate Luminescence Counter (Packard, Meriden, CT). Absolute ATP values 
were determined using an internal ATP standard (Sigma-Aldrich). Approximately 1 × 
106 cells/mL were used, with absolute levels quantified by DNA detection as described. 
 
3.3.7 Cell quantification by DNA detection 
Cells were quantified by lysis and subsequent DNA staining following the method of 
Benech, et al. [68]. Jurkat cells were lysed in 200 μL Glo lysis buffer (Promega, Madison, 
WI) and centrifuged (1,600 g for 5 min.) at 4 ºC. SYBR Green (Sigma-Aldrich) was 
diluted 1000-fold in ultrapure water immediately before use, with 35 μL of dye combined 
with 20 μL of sample and 15 μL PBS in each assay, which was performed in triplicate. 
Samples were measured in a 96 well plate with background wells, and fluorescence was 
measured using a Fluoroskan Ascent Fl with excitation and emission wavelengths of 496 
nm and 590 nm respectively. Absolute cell numbers were obtained using an internal 
counting standard determined by trypan blue staining. 
 
3.3.8 A Single Cell-based Assay to Detect Cell Death Parameters 
As shown in Figure 3.1, the ROS induced cell death is a very complex process. Different 
parameters are used to understand and quantify this complex process, including 
mitochondrial function, apoptosis, and DNA repair. As the first step to investigate these 
cell death events, we set up the simultaneous experimental measurements to evaluate 
mitochondrial membrane depolarization, cell morphology changes, intracellular ATP 
level, apoptotic-dependent cell death pathways, intracellular ROS level, and cell viability. 
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We also co-treat cells with a sub-lethal but nearly apoptotic dose of H2O2 to simulate the 
impact of elevated oxidative stress during apoptosis. Treatment of human cells by H2O2 
has been found to induce oxidative DNA damage, recovery and repair, apoptosis, and 
non-apoptotic cell death, depending on the dose of H2O2 and intracellular ATP levels 
[25-28]. 
These preliminary experimental data can increase the information and minimize 
errors for us to make the decision. The critical problem is that how to develop an 
experimental model which can make the decision on both design scope and level of 
details. One single assay is definitely not considered sufficient to determine the 
mechanism of cell death. Complementary to one single assay, an experimental model 
including all known components and relevant phenomena is impossible, time and money 
consuming. Towards this goal, we combined several investigation techniques into one 
single flow cytometric assay of cell death. We refine our hypothesis and experimental 
design based on the quantitative preliminary results. As shown in Figure 3.4, we selected 
phenotypic variables upon perturbations to characterize the relative role of system 
components, and develop an experimental model of cell response on cell death stimulated 
by the mitochondrial uncoupler. We designed innovative protocols, assay technologies, 
and data analysis techniques to obtain plausible flow cytometry data. We collect the 
experimental data through flow cytometry, and design the Matlab code to automatically 
process and analyze flow cytometry data. The histogram-based metrics was employed to 
define cell population fractions instead of the traditional identification using the 
fluorescence intensity arbitrary values. This approach reduced the noise caused by the 
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potential artifactual oxidation of dyes through dye-based methods in flow cytometry and 
provided the data to better understand the mechanisms of system perturbations. 
 
 
 
  
Figure 3.4 Technological design for flow cytometry assay. 
 
 
 
3.3.9 Modeling Procedure 
The equations that constitute various alternative models are given in details in the Results 
section. In general, we solve equations and perform parameter estimation with Matlab 7.0 
R14 (The Mathworks, Inc., Natick, MA) running on a PC with a Pentium IV processor. 
We employ a stiff ODE solver (‘ode15s’) and Levenberg-Marquardt nonlinear least 
squares regression (‘lsqcurvefit’) with starting values tested for consistency. 
Fit errors are reported through a calculated R2 coefficient based on the sum of 
squares error. Briefly, adapting methods described in [69], the sum-of-squares (SS) from 
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least squares nonlinear regression is the sum of the squares of the vertical distances of the 
curve. We obtain model parameters by varying the values of the model parameters to 
minimize SS. There are two SS values calculated for this regression model, SSreg and SStot. 
SSreg is the square of the vertical distances between experimental data points and 
regression curve, shown as Equation 1, where ˆ y is the values from regression model 
and y is the experimental data as a function of time points (x). SStot is the square of the 
vertical distances between experimental data points and their mean, shown as Equation 2, 
where y  is the mean of all experimental data points. 
 
SSreg = ˆ y − y( )∑ 2                (1) 
SStot = ˆ y − y ( )∑ 2                (2) 
 
Also, the standard deviation (SD) of the estimated points from regression model is 
Sy.x., which is calculated from Equation 3, where N is the number of data points, P is the 
number of parameters, and N - P is the number of degrees of freedom. 
 
SSy.x =
SSreg
N − P                (3) 
 
The value of R2 quantifies goodness of fit. Higher values indicate that the curve 
comes closer to the data for nonlinear regression. R2 is calculated using the Equation 4. 
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R2 =1− SSreg
SStot
                (4) 
 
Given this definition of R2, it does not have to be a positive number. A negative R2 
means that the fit curve has greater error than a straight line at the mean value of 
experimental data.  
In addition, model evaluation and selection are determined through Akaike’s 
Information Criterion (AIC) method [69], which tells how well the data support each test 
model. The corrected AICC score is calculated from Equation 5, where N is the number 
of data points, K is the number of parameters plus one, and SSreg is calculated from 
Equation 1. Compared with AIC score, AICC is more accurate for small sample sizes in 
biology data analysis. According to the theoretical basis of AICC method, the model with 
the lowest AICC score is most likely to be correct.  
 
AICc = N ⋅ ln SSregN
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ + 2K +
2K ⋅ (K +1)
N − K −1          (5) 
 
Once parameter estimates are obtained, we generate confidence intervals for them 
by Monte Carlo simulation. These confidence intervals represent the range of variation in 
parameters that would still lead a 95% likelihood of the best fit to data, assuming a 
Gaussian error based on the standard deviation for replicates measured at each time point. 
This provides a rigorous basis to evaluate robustness of the model and compares the 
curve fits to different data series. Therefore, we add random scatter for each estimated 
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data point generated by the regression model based on the triplicate measurements at 
each point. This random scatter is drawn from a Gaussian distribution with a mean of 
zero and a standard deviation equal to SSy.x reported by nonlinear regression of the 
experimental data. Fitting the simulated data with nonlinear regression model will 
generate another set of best-fit parameters. Then, we repeat this process 100 times, and 
compute new values for best-fit parameters with simulated experimental data, thus 
computing the distribution of parameter estimates to obtain the confidence interval. 
The parameter sensitivity analysis is performed using finite difference method, as 
shown in the Equation (6) [70, 71]. x  represents variables and θ  represents 
parameters. The parameter sensitivity matrix Sij  examines the parameters influence on 
the system perturbation.  
         (6)  
where i ∈ [1,N], j ∈ [1, M]. N is the number of variables, and M is the number of 
parameters. In order to direct compare the sensitivities to parameters having different 
nominal magnitudes, we normalized the sensitivity coefficients Sij  in the Equation (7): 
              (7) 
 
3.4 Results 
3.4.1 Experimental Results 
3.4.1.1 Optimization of Culture Condition and Stimulation for Studying Cell Death 
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Our aim is to set up the optimized conditions of cell stimulation and obtain conventional 
data to be compared with the results obtained from signal cell based flow cytometry, The 
stimulation procedure was optimized prior to flow cytometric measurement. 
Additionally, dynamic behavior of cell death was measured by caspase-3 activation and 
ATP depletion.  
Firstly, we measured intracellular ATP and caspase-3 of Jurkat cells in CCCP 
stimulation, shown in Figure 3.5. We sought to obtain quantitative data for caspase-3 and 
ATP levels that did not depend on cell number. Simple visual cell counting with a 
hematocytometer tends to lead to a high degree of noise. To normalize these 
measurements to the number of cells, samples from the cell populations used in each 
experiment were taken, lysed, and then quantified by DNA staining as described in the 
Methods and [16]. In addition, we calibrated both caspase-3 activity (cleavage of the 
caspase-3 substrate conjugated with fluorescent R110) of protein lysates and intracellular 
ATP (luminescence generated by luciferase reaction) using reference standards. 
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Figure 3.5 Signal cell based ATP and caspase-3. Grey bars and black bars were for 
measurements of untreated cells and CCCP treated cells respectively.  Plot (A) shows 
intracellular ATP quantified by signal cell. Plot (A) shows caspase-3 quantified by signal 
cell. 
 
 
 
Figure 3.5 shows quantified intracellular ATP levels and caspase-3 activity of whole 
cell extracts in CCCP stimulation. Over the course of the time series, ATP levels are 
significantly higher (p < 0.05) for untreated cells than CCCP treatment. The normalized 
caspase-3 activity of CCCP treated cells is significantly greater than that of untreated 
cells for all time points (p < 0.05).  
Jurkat cells were exposure to various dose of NAC (0.1mM, 1mM, and 3mM), 
shown in Figure 3.6. To determine the best efficient dose of NAC, we treated Jurkat cells 
with CCCP and NAC together after 2 hours NAC exposure. 1mM NAC reduced 
intracellular ROS and dead cell population, inhibited mitochondrial membrane 
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depolarization and caspase-dependent apoptosis, shown in Figure 3.6. 1mM was the most 
appropriate concentration for Jurkat cells, and was used for flow cytometry measurement.  
 
 
 
 
Figure 3.6 NAC dose response in CCCP exposure. Jurkat cells were pre-treated with 
various dose of NAC for 2 hours, followed by treated with CCCP (denoted ‘C’) +NAC 
for 5 hours. Untreated cells was denoted ‘Un’. Plot (A) shows the normalized alive cells 
population stained by PI dye. Plot (B) shows signal cell based caspase-3 protein. Plot (C) 
and (D) show MMP signal and ROS signal for P1 group.  
 
 
 
3.4.1.2 CCCP Induces Cell Death in Jurkat Cells 
For analysis of model parameter estimation and robustness, two data sets were collected 
for CCCP exposure. Both data set A and data set B were treated exactly the same, and 
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data for all variables (MMP, ROS, and cell death) were collected at 30 min. after 
treatment, and at time points every hour from 1-8 h after treatment following the same 
procedure. Untreated cells were measured at various subsequent time points; there was no 
significant change in variable levels for untreated cells in any experimental time series 
(data not shown) and so the average value at one time point was used as the 0 h time 
point for modeling. Experimental data sets A and B for the variables used to generate the 
models are provided in Additional File 1, while all experimental data (i.e., flow 
cytometry data files) are available from the authors upon request. Figure 3.7 shows plots 
of the experimental data for key variables (along with modeling results described in the 
subsequent section). 
 
51 
 
 
 
Figure 3.7 These plots summarize of experimental and modeling results for CCCP 
treatment, including data sets A and B as described in the text. Plots A~C show the 
results for data set A (squares for experimental results). Plots D~F show the results for 
data set B (triangles for experimental results). Simulation results from Model III are 
shown in solid lines and simulation results from Model IV are shown in dash lines. Error 
bars are shown as the standard error for triplicate experiments. As indicated, the plots are 
(A) and (D) for the fraction of cells denoted [MMP-] (stained negative indicating 
mitochondrial permeabilization indicative of mitochondrial membrane depolarization has 
occurred), (B) and (E) [ROS high] (stained with a higher ROS than reference untreated 
cells adjusted as described in text), and (C) and (F) [cell deads] (YOPRO-1 positive as 
indicated by the example in Figure 1). For (B), (C), (E) and (F), simulation results for 
Model III and Model IV are overlap.  
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3.4.2 Model Development 
Our goal in this section is to generate a data-driven model of the changes in phenotypic 
variables with time upon CCCP stimulus and develop an approach to distinguish with 
different biology hypothesis of how cell death stimulated by CCCP. The variables that 
can be included are experimental observables generated by gating and population 
definition based on conventional flow cytometry methods, specifically the proportion of 
[MMP-] (representing the population fraction with mitochondria permeable to TMRE 
dye, i.e., with a low mitochondrial membrane potential following depolarization), [ROS 
low] / [ROS high] representing the fractions of population defined with relatively low 
and high ROS, and [live cells] / [dead cells]. In the latter case, [dead cells] may be 
interpreted as meaning [dying cells], since these cells may either be dead or in a “late 
apoptotic” stage with increased membrane permeability and altered morphology that 
resemble dead cells [65]. 
As shown in Figure 3.8, the hypothesis tree is generated based on the relationships 
among these components in cell alive/death decision system. Our aim is to identify the 
dominant factor that regulates cell death in CCCP stimulation. For each possibility, we 
examine the dynamic interaction between these factors, followed by different 
mechanisms of how CCCP interact with the cell system.  
 
53 
 
 
 
Figure 3.8 Hypotheses tree generation for comparative analysis of the role of ROS 
or. mitochondrial membrane defect in cell death.  
 
 
 
This hypothesis tree represents all of the testable experimental trials. The traditional 
biological approach is to use experiments to validate each hypothesis. Instead of doing 
costly and time-consuming exhaustive experimental testing of all hypotheses, we use 
modeling approach to select the best hypothesis to optimally select the next experiment. 
As Figure 3.8 shows, for our problem we have 12 testable hypotheses. Then, we modeled 
each hypothesis with the a set of ordinary differential equations based on conservation of 
the experimentally observed quantities 
Notably, because the system variables are normalized (sum to 1) values, these 
population fractions can be interpreted in the context of a cell-based model as 
probabilities that an individual cell exists in those particular states (i.e., alive or dying). 
However, there is always more than one mathematical formulation can describe one 
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hypothesis. Using cell death transition as an example, we assume that ROS high is the 
dominant factor for cell death stimulated by CCCP. For this hypothesis, we can use hill 
equation to describe this process, as described in equation (6). Alternatively, we can use 
the exponential saturation function to describe this process, shown in equation (7). Or, we 
can use logistic equation to describe the death term, shown in equation (8). After we 
combine all of the possible mathematical formulation for each hypothesis, we have 96 
models now, as shown in the supplementary file 2.  
 
         (6) 
        (7) 
      (8) 
 
 
 
3.4.3 Model Verification and Model Selection 
For the purpose of comparing the differing assumptions behind the models, we employ 
the goodness of fittings and robustness of models as the major factors to determine the 
performance of prediction. Data set A was used as “training data” and data set B was 
used as “test data”. We fit all of 96 models to the training data using 
Levenberg-Marquardt nonlinear least squares regression. Moreover, we also compared 
the robustness performance of models using parameters from training data to fit test data 
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to see if the model is robust enough for the changes of variables measured in 
experiments. Figure 3.9 is the flow chart to show how to identify the best model which 
can explain the mechanism of the system perturbations. The calculated Akaike’s 
Information Criterion scores are used to determine the robustness of the models. The best 
prediction was selected on the robustness of the model.  
 
 
 
 
Figure 3.9 Scheme of model selection.  
 
 
 
We cut off the AIC scores at -30 and select the models with AICc score less than -30 
for the training data, as shown in Table 1. As shown in the table, ‘training to training’ 
means using parameters from training data to fit themselves, and ‘training to test’ means 
using parameters from training data to fit test data.  
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These eight models developed to present different hypothesis of how cell death 
stimulated by CCCP and what are the dynamic interactions between system variables. 
Equation 6 describes the probability of a cell having a mitochondrial membrane 
permeability transition as the overall results of CCCP stimulus and ROS elevation. It is a 
first order linear equation, assuming that (a) CCCP diffuses quickly throughout the 
medium, and (b) the mitochondrial membrane depolarization is at least partially driven 
by ROS state transition. The transition rate is modeled with saturation term where k1 
represents the overall transition rate caused by CCCP stimulus and ROS elevation over 
time. Equation 7 describes the transitions between [ROS low] and [ROS high] states, 
where [ROS low] is replaced by (1 – [ROS high]) through conservation of mass. This 
model assumes that the increase in ROS is proportional to the impact of CCCP on 
mitochondrial membrane depolarization (k2[MMP-]). We also subtract a transition from 
[ROS high] back to [ROS low] with transition rate k3. This backward transition is used to 
reproduce the recovery process, which might occur for the apoptotic cells (i.e. the dying 
cells). Equation 8 models cell death using a Michaelis-Menten formulation, suggesting an 
enzyme or pathway process depending on the transition of the cell to a high ROS state. 
Table 1 shows the AIC scores for the model (Model I) with parameters estimated using 
data set A. 
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d[MMP−]
dt
= k1 ⋅ ROShigh[ ]⋅ (1− [MMP−])          (6) 
d[ROShigh ]
dt
= k2 ⋅ [MMP−] ⋅ 1− ROShigh[ ]( )− k3 ⋅ [ROShigh ]      (7) 
d[dead]
dt
= k4 ⋅ [ROShigh ]
k5 + [ROShigh ]
⋅ 1− dead[ ]( )         (8) 
 
The system of Equations 6-8 (Model I) assumes that the ROS state transition drives 
the cell death process. We also considered the fit quality of three alternative models 
based on the same assumption that ROS state transition is directly producing cell death 
under CCCP exposure, but with different ROS and MMP transition processes. In Model 
II, we assume that the mitochondrial membrane permeability transition is independent of 
[ROS high] with Equation 9 substituting for Equation 6. In Model III, we assume that the 
transitions between [ROS low] and [ROS high] states are independent of mitochondrial 
membrane permeability transition with Equation 10 substituting for Equation 7. In Model 
IV, both MMP transition and ROS transition are independent with Equation 9 and10 
substituting for Equation 6 and 7 respectively.  
 
d[MMP−]
dt
= k1 ⋅ (1− [MMP−])            (9) 
d[ROShigh ]
dt
= k2 ⋅ 1− ROShigh[ ]( )− k3 ⋅ [ROShigh ]        (10) 
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Model V-VIII evaluate the possibility of the MMP transition directly driving cell 
death. For Model V-VIII, we assume that mitochondrial membrane depolarization 
directly induces cell death under CCCP exposure using Michealis-Menten (Equation 11 
substituting for Equation 8). Different ROS and MMP transition processes were tested 
through different [MMP-] and [ROS high] ODEs. Equation 6 and 7 are retained for 
Model V, Equation 9 and 7 are retained for Model VI, Equation 6 and 10 are retained for 
Model VII, and Equation 9 and 10 are retained for Model VIII.  
 
d[dead]
dt
= k4 ⋅ [MMP−]
k5 + [MMP−]
⋅ 1− dead[ ]( )          (11) 
 
As shown in Table 3.1, Model III and Model IV perform well on both criteria. 
Table3.2 shows the parameter values generated by fitting Model III and Model IV to 
training data and test data (parameter ranges were generated by stochastically simulating 
confidence intervals). These were used to generate the corresponding curves in Figure 
3.7. Both Model III and Model IV propose that the ROS state transition drives the cell 
death process by CCCP stimulus and that the ROS transition is independent of 
mitochondrial membrane depolarization. However, these two models don’t agree on 
whether mitochondrial membrane depolarization is coupled with ROS state or not. 
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Table 3.1 AICC scores for fits to alternative models 
Training to Training Training to Test 
Models [MMP-] 
[ROS 
high] [Death]
Ave. 
AIC [MMP-] 
[ROS 
high] [Death] 
Ave. 
AIC 
   I -4.60 -59.92 -56.58 -40.36 -14.51 7.24 -38.33 -15.20 
   II -13.34 -50.27 -56.23 -39.95 -32.17 -0.71 -53.61 -28.83 
   III -5.15 -82.94 -54.95 -47.68 -63.52 -5.71 -59.83 -43.02 
   IV -14.54 -84.32 -54.98 -51.28 -29.35 -5.74 -59.87 -31.65 
   V -4.59 -60.34 -38.98 -34.64 -14.48 7.14 -26.98 -11.44 
  VI -13.38 -50.18 -45.63 -36.39 -32.07 -0.70 -42.83 -25.20 
  VII -5.36 -83.80 -38.78 -42.65 -68.01 -5.73 -36.75 -36.83 
  VIII -14.77 -81.32 -45.66 -47.25 -28.87 -5.68 -42.80 -25.78 
 
 
 
We modeled the system with the following set of ordinary differential equations 
based on conservation of the experimentally observed quantities, and the simulation 
results (using AIC determined experimental data) are plotted in Figure 3.7 along with 
experimental data. The complexity of the model presented here is constrained by the size 
of the expected data set to minimize over-fitting. 
 
3.4.5 Model Improvement 
3.4.5.1 Parameter estimation sensitivity analysis for selected models 
One of the key issues with nonlinear least squares for parameter estimation is that the 
local optimum may not be the global best fit. To test this, we evaluated the consistency of 
parameter estimations for Models III and IV for ranges of different initial parameter 
guesses. Because of the large parameter search space due to combinatorial explosion, we 
explored the space through two sets of sensitivity analyses. The first test was fitting 
parameters to data set A with uniform initials guesses for all parameters set at 0.05, 0.1, 
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0.25, 0.5, 0.75, 1, 2, 5, and 7. The second test was fitting parameters to data set A with 
variable initial guesses: starting with the parameters obtained for data set A using a 
uniform initial starting guess of 1.0 (i.e., those shown in Tables 3.2 and 3.3) multiplied by 
factors of 0.05, 0.1, 0.25, 0.5, 0.75, 1, 2, 5, and 7. These ranges of initial values were 
chosen to be plausible within the context of our biological models. Figure 3.10 shows 
parameter estimates (normalized by dividing by the values in Table 3.2) from Model III 
with uniform initial guesses and variable initial guesses respectively. The analysis of 
Model IV showed similar results (plots not shown). 
 
Table 3.2 Parameters for Model III with confidence intervals 
Data 
Set A Parameters CI 
Data 
Set B Parameters CI 
k1 0.231 [0.163 ; 0.296] k1 0.212 [0.206; 0.216] 
k2 0.527 [0.502; 0.547] k2 0.697 [0.695; 0.700] 
k3 0.032 [0.023; 0.040] k3 0.008 [0.07; 0.08] 
k4 0.504 [0.501; 0.507] k4 0.393 [0.393; 0.393] 
k5 13.953 [13.920; 13.965] k5 11.117 [11.116; 11.118] 
 
 
 
Table 3.3 Parameters for Model IV with confidence intervals 
Data 
Set A Parameters   CI 
Data 
Set B Parameters    CI 
k1 0.151 [0.124 ; 0.173] k1 0.149 [0.138; 0.158] 
k2 0.526 [0.526; 0.526] k2 0.705 [0.705; 0.705] 
k3 0.032 [0.032; 0.032] k3 0.010 [0.01; 0.01] 
k4 0.486 [0.486; 0.486] k4 0.442 [0.442; 0.442] 
k5 13.406 [13.406; 13.406] k5 12.625 [12.625; 12.625] 
 
 
 
To analyze the determinability of parameters, the correlation coefficients between 
each pair of estimated parameters were calculated. We found that k2 and k3 are highly 
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correlated with each other, and k4 and k5 are highly correlated with each other (data not 
shown). As shown in Figure 3.10, k1 k2 and k3 are consistent no matter what are the 
starting points for fitting. Also, k4 and k5 increase proportionally to their initial values, 
which suggest us that the ROS induced cell death process might be a linear process. 
Thus, we tested the hypothesis that cell death can be modeled as being linearly dependent 
of the transition to a high ROS state by replacing Equation 12 substituting for Equation 8 
for both Model III and Model IV. Table 4 shows the AICC scores for Model III and 
Model IV with different models for death mechanisms. These linear death models have 
lower AICC scores as compared to the model with a Michaelis-Menten formulation. 
d[dead]
dt
= k4 ⋅ [ROShigh ] ⋅ 1− dead[ ]( )          (12) 
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Figure 3.10 Stability analysis of parameter estimation.  
 
 
 
3.4.5.2 Parameter Sensitivity Analysis by Finite Difference Method 
We calculated the model sensitivity matrix Sij  as describe in Methods section. As an 
example, Figure 3.11 shows the dependence of [Death] on changes in each of five 
parameters at nine different time points subsequent to the initial treatment time (“time 
0”).  
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Figure 3.11 Parameter sensitivity analysis of the model variable [death] for model 
III in CCCP stimulus.  
 
 
As shown in Figure 14, the first parameter is for MMP transition, and 2nd and 3rd 
parameters are for ROS transition, and the last two parameters are for cell death 
transition. We recognize that this model variable [death] is more sensitive with parameter 
2 and parameter 4, which are the production terms for ROS generation and cell death, 
especially during the late time points. This is consistent with our assumption that ROS is 
the dominant to determine cell death in CCCP stimulus for the selected model.  
 
3.4.5.3 Sensitivity-dependent Correlation Matrix 
64 
 
 
We obtained the M × M sensitivity-dependent correlation matrix of the parameters as 
described in Methods. Each parameter has a correlation strictly between -1 and +1 with 
each of the other parameters. For example, if a parameter has a correlation of exactly -1 
with one other parameter, this means that these two parameters influence the model 
outcome in exactly the opposite manner. Complementary to this, +1 means these two 
parameters influence the model outcome in exactly the same manner. As shown in Figure 
3.12, Plot A shows the parameter correlation matrix at the early time point, Plot B shows 
the parameter correlation matrix at the late point, and Plot c shows the parameter 
correlation matrix summarized over all nine time points. We recognize that these 
parameter 4 and parameter 5 for cell death transition are highly correlated. Recalling the 
model development stage, we use Michaelis-Menten formulation to describe the cell 
death transition dependent on ROS state.  So, this high correlation suggests us that this 
transition might be a linear process. 
These correlations suggest fitting a model to the data we obtained did not require a 
full Michaelis-Menten formulation for the potentiation apoptotic pathways that finally 
resulting in cell death [62, 64]. The likely reason for this is that the data do not show 
enough complexity to fully determine a nonlinear model. As the calculated AICC scores 
shown in Table 3.4, a simple linear cell death model more parsimoniously explains 
experimental data. Thus, we propose the use for the straightforward and computationally 
efficient method shown here to effectively simplify nonlinear models and reveal 
parameters that cannot be determined using available data. 
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Figure 3.12 Parameter Sensitivity Analysis of the model variable [death] for model 
III in CCCP stimulus.  
 
 
Table 3.4 AICC scores for Model III and Model IV with different death mechanisms 
Training to Training Training to Test 
Models [MMP-] 
[ROS 
high] [Death]
Ave. 
AIC [MMP-] 
[ROS 
high] [Death]
Ave. 
AIC 
III 
(lin.) -14.15 -92.98 -63.33 -56.82 -72.55 -14.74 -68.04 -51.78 
IV  
(lin.) -23.54 -93.59 -63.31 -60.15 -38.35 -14.74 -68.02 -40.37 
III  
(M-M) -5.15 -82.94 -54.95 -47.68 -63.52 -5.71 -59.83 -43.02 
IV  
(M-M) -14.54 -84.32 -54.98 -51.28 -29.35 -5.74 -59.87 -31.65 
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3.4.6 Independent Validation of the ROS-mediated CCCP-induced Cell Death 
Model 
To evaluate our consistent finding of a ROS-mediated, CCCP-induced cell death model, 
we collected data for cells treated with a combination of antioxidant NAC and CCCP at 
1, 2, 3, 4, 5, 6, 7, and 8 h. Figure 3.13a shows the level of dead cells as compared to 
CCCP-exposed cells in data set B, showing a marked increase in cell survival across all 
time points for cells co-treated with NAC. (We found no effect of NAC on the survival of 
untreated Jurkat cells in repeated trials at the dose used in this experiment.) Figures 
3.13b-c qualitatively shows the clear impact of NAC on high ROS state and 
mitochondrial membrane potential. The corresponding parameters for the CCCP-only 
exposed cells and cells co-treated with NAC are shown in Table 3.5. The results show 
both a reduction in the MMP state transition rate and a substantially reduced level of 
ROS state transition in cells treated with NAC. 
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Figure 3.13 Data shown here are for cells treated with CCCP and CCCP + NAC 
(with CCCP data from Data Set B for cell death and a repeated experiment for other 
variables) treated as described in the Methods section. Experimental results are shown 
here for CCCP (black bars) and CCCP+NAC (grey bars) with error bars shown as 
standard errors of triplicate experiments. The stars indicate data points for which the 
unpaired two-sided Student’s t-test yielded p values of less than 0.05, suggesting a 
statistically significant difference in cell viability due to NAC pre-treatment. Plots are (A) 
population fraction of [MMP-], (B) population fraction of [ROS high], and (C) 
population fraction of dead cells.  
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Table 3.5 Parameters of Model III and Model IV for fitting CCCP and CCCP+NAC 
data 
  Model III Model IV 
Parameters CCCP CCCP + NAC CCCP CCCP + NAC 
k1 0.231 0.058 0.151 0.002 
k2 0.527 0.703 0.526 0.740 
k3 0.032 19.753 0.032 20.790 
k4 0.504 1.154 0.486 1.048 
k5 13.953 18295.283 13.406 19094.389 
 
 
We calculated the model sensitivity matrix for CCCP+NAC treatment, as shown in 
Figure 3.14. Same as Figure 14, the first parameter is for MMP transition, and 2nd and 
3rd parameters are for ROS transition, and the last two parameters are for cell death 
transition. As shown in Figure 3.14, it is clear that the cell death variable is sensitive to 
parameter 3 and parameter 5 parameters during the early time points, which are the 
inhibition term for ROS transition and cell death transition respectively. Compared with 
Figure 3.11, the model variable [death] of CCCP+NAC treatment is more sensitive on 
ROS transition inhibition term instead of ROS production term on CCCP exposure only.  
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Figure 3.14 Parameter Sensitivity Analysis of the model variable [death] for model 
III in CCCP+NAC stimulus.  
 
 
 
3.5 DISCUSSION  
In this paper we address the issue of analyzing data through a mechanistic model based 
on cytometric data on phenotypic variables for a ROS-mediated cell death process. More 
detailed models for cell death pathways do exist, but they generally focus on detailed 
protein interactions and reaction mechanisms, for example, including the activities of 
caspases [72], signal transduction pathways [56], and the dynamics of Bcl-2 and Bax 
[73]. These models however have drawbacks that prevent practical applicability. One key 
problem is that they are designed for idealized or specific inducers of apoptosis, as 
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opposed to being general and applicable to a different kind of inducer such as CCCP. 
Another significant problem is that they contain many variables and parameters, which 
means that they are susceptible to “over-fitting” realistic experimental data sets. That is, 
even with substantial adjustments to parameter values or the absence or presence of 
different variables, the models could still fit the data – thus their interpretation requires 
many unjustified assumptions. 
A complementary approach is to start with the data to develop a model based on 
experimental observed variables, which are not as susceptible to over-fitting. Then, over 
time as additional information is obtained, these “top-down” (data-driven) models can be 
enriched and connected to the “bottom-up” (molecular knowledge-driven) pathway-based 
mechanistic models. A start to this approach was the work of Fennell, et al. in estimating 
the kinetics of whole cell mitochondrial membrane potential depolarization as a Bernoulli 
probabilistic transition [74]. This simple model used the average rate of mitochondrial 
membrane potential collapse as a stochastic variable to derive kinetics of apoptosis. We 
generalize this approach to include more observable variables. The test case presented 
here includes phenotypic outcome variables of mitochondrial membrane potential 
(MMP), intracellular oxidative potential representing the level of reactive oxygen species 
(ROS), and cell death. Moreover, the basic approach we describe can be easily applied to 
any cell-based measurements of other variables such as intracellular pH, expression of 
proteins tagged with GFP, or intracellular protein concentration measured by antibody 
staining of fixed cells. 
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In this paper, we have applied modeling to data sets representative of practical 
biological experiments. They include limited numbers of time points and realistically 
noisy quantities. The well-known difficulties of quantifying ROS based on fluorescent 
probes [67]  limit our ability to interpret changes in data collection. Thus, new 
technologies will likely need to be developed before improved quantitative data can be 
obtained. Our ROS and MMP quantification methods can minimize inter-sample 
variability caused by potential artifactual oxidation and increase the sensitivity of 
measurement through dye-based flow cytometry measurement. In addition, we measure 
variables in short time points to avoid cell proliferation over longer time scales [75] and 
potential over-fitting problem to a model with more equations and parameters. Moreover, 
we design the training data and test data which were collected following exact the same 
protocol, but from experiments performed with different reagent lots and measured at 
different times. Thus, the results we show here are representative of what can be expected 
for data-driven modeling, in particular in terms of reproducibility of model parameter 
estimation. As Tables 3.2 and 3.3 indicate, parameters obtained on different data sets are 
similar, especially for the MMP transition rate k1. Though the confidence intervals of 
parameters for ROS transition and cell death process for training data and test data are 
not overlap, the ratio between k2/k3 and k4/k5 for training data and test data are 
qualitatively similar, which determine the similar system perturbations over time.  
Despite the caveats of noisy biology data, our models were able to quantify the 
effects of CCCP on ROS, MMP, and cell death processes. Model development covers the 
general possible hypothesis of how cell death stimulated by CCCP and what are the 
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dynamic interactions between system variables. Model evaluation with AICC scores is 
more rigorous comparing with the traditional R2 fit error. It balances the goodness-of-fit 
vs. the complexity of the models (i.e. number of parameters), which allows us to decide 
between a variety of hypotheses or models about how the perturbation is caused in 
biology systems. The model robustness analysis is able to select the best model that is 
robust enough for the changes of variables measured in experiment. The superior 
performance of Model III and Model IV as compared to Model V~VIII supports the 
primary role of CCCP in the mitochondrial membrane permeability transition, followed 
by ROS increase, as well as the connection between the ROS increase in cell death, as 
opposed to cell death being just a function of mitochondrial membrane permeability and 
cytochrome c release. This is also supported by our results showing that cell death is 
inhibited by NAC, which has an antioxidant role [76]. Interestingly, as Figures 3.7b-c 
show, MMP and ROS increase at the earliest time point (30 min) while at all subsequent 
time points they are suppressed. This cannot currently be explained in the context of our 
model and suggests the need for a more complex mechanism including the effect of NAC 
on MMP.  
In this paper, we also implement a practical method to avoid the local optimality 
problem of finding the best parameter estimation. Much of the work in this area 
emphasizes the need to solve a global optimization problem. However, the problem is not 
as simple as just being trapped in a local minimum R2 error level that represents a 
sub-optimal parameter estimation. The different minimal R2 error values are often either 
identical or essentially the same. This is not only because of the relatively small amount 
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of data (constrained by practical limits on biological experiments) but also because of the 
nonlinear nature of the system. Instead, it is more significant to analyze the multiple error 
minima to derive informative patterns in the parameter estimates. These patterns can lead 
us to robust conclusions about the behavior of the nonlinear system we are analyzing. 
We also employ parameter sensitivity analysis. As suggested in Figure 3.14, NAC 
inhibits cells death through mediating ROS generation. Indeed, this parameter sensitivity 
analysis can exam how these estimated parameters influence the system outcomes. This 
will help us to further understand the dynamic changes of system perturbations. 
Therefore, we performed sensitivity analysis on the initial guesses for the nonlinear 
least squares estimation of parameters. To perform a computationally efficient search of 
the large space of potential parameter values, we performed sensitivity analyses with 
uniform initial parameter guesses and variable initial parameter guesses. As shown in 
Figure 3.10, k1 k2 and k3 are consistently estimated, representing robust parameter fits for 
the ROS-mediated MMP-transition model. However, the parameters for cell death, k4 and 
k5, were found to increase proportionally to their initial guesses. Turning to the 
biological interpretation of our modeling analysis, the key question to consider is the 
source of increased intracellular ROS in the Jurkat cells we studied. Interestingly, despite 
the data shown here, as a mitochondrial uncoupler, CCCP could theoretically inhibit ROS 
generation by the electron transport chain, an effect that was previously observed shortly 
(less than 1 hour) after treatment [77, 78]. Still, the mitochondrial permeability transition 
(MPT) pore has been directly associated with intracellular ROS levels [79-82]. The time 
scale may be significant: results described in [78] also show initial reduction in ROS over 
74 
 
 
15 minutes was restored in 4 hours. However, in line with what we have shown here, 
there does exist previous data for early and significant increase in ROS with CCCP 
treatment in human leukemic cells [83]. These conflicting time scales suggest the need of 
data-driven modeling to compare different experiments. Rather than focusing on those 
experiments that can best demonstrate a qualitative point, whole data sets can be 
compared to each other and commonalities may become evident. 
One possible explanation for the increase in ROS could be that in general, some 
groups have found that pro-apoptotic agents induce ROS in a respiratory chain-dependent 
fashion [82, 84]. There is evidence of caspase-3 dependent ROS generated in apoptosis 
[85]. But, it should be noted we observed ROS induction by CCCP at early time points. 
Furthermore, CCCP is a strong respiratory chain uncoupler, suggesting a different 
mechanism. Thus, another potential source may be production of O2- at the mitochondrial 
pore [86] during CCCP treatment. These superoxide ions may not be converted to H2O2 
and may be rapidly scavenged under certain conditions, leading to the kind of conflicting 
results observed in the literature. Another possibility is that glutathione may be actively 
transported out of the cell during apoptosis, as suggested in [87]. This would account for 
the ability of NAC, a glutathione precursor, to counteract the effect of ROS loss (though 
that may also still in part still be due to inhibition of CCCP-induced effects). 
 
3.6 Further Quantitative Analysis of the Impact of Mitochondrial Membrane 
Depolarization on Cell Death 
3.6.1 Experimental and Computational Models for CCCP Dose Response 
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Based on the work that was done on this paper that was recently submitted, we sought to 
further study the pivotal role of mitochondria on cell death, we treat the Human 
T-leukemic Jurkat cells with different CCCP doses at 1/3X, 2/3X, 1X, 2X, 3X, 4X, and 
5X. The doses were selected based on the sensitivity of the cell line for CCCP. All the 
flow cytometry data for [MMP-], [ROS], and [Death] were collected at 2hr, 4hr, and 6hr. 
The data collection and analysis were following the same methods as described in 3.3.2 ~ 
3.3.7. The modeling methodology were the same as CCCP dynamic modeling as 
described in 3.3.8.  In general, we fit all three data sets at 2hr, 4hr, and 6hr together, and 
the estimated parameters were used to quantitatively analyze the dynamic roles of 
mitochondrial membrane depolarization on cell death.  
 
3.6.2 Results and Discussion 
Figure 3.15 shows the loss of mitochondrial membrane potential associates with CCCP 
dose increase. Figure 3.16 shows the dynamic curve of experimental and computational 
results for mitochondrial membrane depolarization on cell death stimulated with different 
CCCP doses. Though there are multiple factors cause cell death in CCCP stimulus, 
higher mitochondrial membrane depolarization definitely induces more cells dead.  
Similar as 3.4.5.2, we also calculated the model sensitivity matrix Sij . Figure 3.15 ~ 
Figure 3.17 show the dependence of [Death] on changes in each of 6 parameters with six 
different CCCP doses at 2hr, 4hr, and 6hr respectively. It is interesting that cell death 
variable is more sensitive to [MMP-] parameters with low CCCP doses, and not sensitive 
at all with 4X and 5X high CCCP doses. This suggests us that the lost of mitochondrial 
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membrane potential is not the factor for the system perturbation with high CCCP dose 
stimulus. According to A. Graaf, etc.’s work [88], the mitochondrial structure disruption 
might be the key factor for cell death with high dose CCCP stimulus.  
Comparing Figure 3.15, which represents short duration CCCP stimulation, with 
Figure 3.16 and Figure 3.17, which represent long duration CCCP stimulation, the cell 
death variable is sensitivity with the ROS production parameter k2 for high CCCP dose 
treatment. This suggests us that the production of intracellular ROS level is another factor 
to induce cell death under high CCCP dose exposure.  
 
 
 
 
Figure 3.15. Parameter Sensitivity Analysis of the model variable [death] for 2hr 
exposure of CCCP with different doses.  
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Figure 3.16 Parameter Sensitivity Analysis of the model variable [death] for 4hr 
exposure of CCCP with different doses.  
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Figure 3.17 Parameter Sensitivity Analysis of the model variable [death] for 6hr 
exposure of CCCP with different doses.  
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Figure 3.18 Prediction of a dose response curve for cell death as a result of changes 
in mitochondrial membrane permeabilization for CCCP dose response at 2hr, 4hr, and 
6hr. 
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CHAPTER 4: FORMULATION OF AN INTEGRATIVE 
MODELING METHODOLOGY FOR DYNAMIC BIOLOGICAL 
SYSTEMS WITH LIMITED KNOWLEDGE 
 
 
 
4.1 Towards a Biological System Modeling ‘Roadmap’ 
Based on the overall modeling methodology we progressively developed through the 
work described in Chapter 2 and Chapter 3, we formulated an overall modeling 
‘roadmap’ to understand the essential features of biological data through data-driven 
modeling approach. Figure 4.1 outlines the roadmap framework. The process starts with 
limited preliminary experimental data and known biological information about the 
system. For example, a preliminary list of system components relevant to the cellular 
behavior being studied has been identified, and there are some time series data for the 
dynamics of these components following a perturbation.. The modeler first generate 
alternative hypotheses to explain all possible mechanisms among these system 
components that govern the behavior being analyzed; for example, the cell survival or 
death decision system we studied in Chapter 3, where preliminary data consisted of time 
courses for intracellular ROS, mitochondrial membrane potential, and cell survival. Then, 
they translate these models to a selected computational algorithm. It is necessary to verify 
that the computer algorithm is appropriate for the mathematical relationships that have 
been defined to represent the interactions of system components. The choice of algorithm 
is important and can influence the prediction made by the model. Parameter estimation is 
then performed using a selected algorithm based on the currently available data on 
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system dynamics. Then, modelers employ the goodness of fit and robustness as the major 
factors to determine the performance of prediction. Finally, modelers do extensive 
stability analysis and parameter sensitivity analysis to address the problem caused by 
overfitting due to the limitation of fitting to time series data. Models are refined based on 
the identifiability of parameters and optimization of the parameter space. 
A critical point is that while the roadmap portrayed in Figure 4.1 goes in one 
direction, it is in fact a LOOP. The key to the integration of modeling and experiments is 
that the process goes in a cycle. Experiments are designed at the end of the modeling 
process to address problems in the parameter space due to limited data and to resolve 
ambiguities between models that fit the data equally well. Optimal perturbations are 
identified, along with perturbation doses and points in time to measure system dynamics 
to present the richest data set for parameter estimation. 
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Figure 4.1 A modeling ‘roadmap’ framework for systematic analysis of biological 
problems characterized by limited data and pre-existing knowledge base. Note that while 
the roadmap here goes in one direction, the aim is to develop a knowledge cycle with 
feedbacks from model refinement to experimental design. 
 
 
 
Why is this data-driven modeling approach crucial for hypothesis evaluation and 
further experimental design? Using ROS induced cell death problem as described in 
Chapter 3 as an example, more detailed bottom-up model do exist, but they generally 
focus on detailed protein interactions and reaction mechanisms, for example, including 
the activities of caspases [72], signal transduction pathways [56], and the dynamics of 
Bcl-2 and Bax [73]. These models however have drawbacks that prevent practical 
applicability. One key problem is that they are designed for idealized or specific inducers 
of apoptosis, as opposed to being general and applicable to a different kind of inducer 
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such as CCCP. Another significant problem is that they contain many variables and 
parameters, which means that they are “over-fitting” realistic experimental data sets. That 
is, even with substantial adjustments to parameter values or the absence or presence of 
different variables, the models could still fit the data – thus their interpretation requires 
many unjustified assumptions.  
The distinction between our work and these bottom-up models is that instead of 
simulating the complexity of biological system, we are focusing on understand the 
essential features of biological data, distinguish between different biological hypotheses, 
and provide clear aim for the next step: experimental design/clinic trial.  
 
4.2 Model Identification with Ordinary Differential Equations (ODEs) 
Systems 
There are numerous techniques that have been proposed for modeling biological systems, 
beyond the systems of differential equations shown in Chapter 3. Among them include 
(references given are only examples of many): hidden Markov models (e.g., [89, 90]), 
Bayesian networks [91, 92], linear neural networks [93], finite state algebra [94], and 
probabilistic Boolean networks [95, 96], and Petri nets, cellular automata simulators, 
agent-based models and pi calculus [10]. An example of a hybrid of using stochastic 
discrete dynamical equations with deterministic equations is the microtubule modeling 
described in Chapter 2, and the Sokhansanj group has previously explored fuzzy logic 
modeling as well.  These and other methods are based on either treating biological 
variables at the crudest resolution (on or off in Boolean networks, a few more levels 
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possible for finite state models but with rapidly growing complexity) or as absolute 
physical quantities. These computational and mathematical approaches to model 
biological systems become a very helpful step in integrating large amounts of varied data 
types.  
Among the creative and elegant mathematical modeling approaches and algorithms 
mentioned in previous sections, the use of ordinary differential equations (ODEs) systems 
is most widespread in biology modeling [97].  The reason why ODE-based models is 
are most commonly used in computational biology is because the biological systems can 
be conveniently viewed as networks of chemical reactions that can be analyzed 
mathematically using ODEs [97-99], especially to simulate the dynamic changes of 
system perturbation over time. For example, ODEs can be used to describe 
monomolecular conversion, reversible conversion, production, degradation, electric 
physiology, intracellular and extracellular signaling, and pharmacodynamic simulation in 
the areas of drug discovery and development [10, 97]. There are certainly drawbacks to 
using ODEs. For example, random processes are known to be significant in regulating 
cell behavior, but we anticipate that the methods described here can be relatively 
seamlessly adapted to stochastic chemical kinetic systems, for example using the 
Gillespie modeling method [100]. Other limitations on using ODE have to do with the 
difficulty in obtaining accurate biochemical data, which we have tried address through 
the extensive sensitivity, stability, and robustness analysis that is essential within the 
roadmap framework. The key challenge remains how to set up a useful ODE model using 
mathematical and biological knowledge and computational skills [101].Our approach is 
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to directly discover ODE equations from experimental data that can faithfully mimic the 
system behavior. Two critical steps are involved in this process. The first is Model 
Development. In this step, a valid model structure needs to be found based on the domain 
knowledge about the cellular systems. The relationship between measured variables and 
how they change over time is described in the model structure. Identifying the model 
structure is the most challenging aspect of Model Development, for it is hard to address 
properly and it can be a very time-consuming exercise to generate and test different 
model structures. Currently, many computational biology researchers are working on 
automatically generate model structures through machine learning techniques, such as 
using evolutionary algorithms [12]. However, how to discover a successful algorithm that 
can perform well on a user-defined task is still an open question. The second is Model 
Identifiability. This step is used to determine how many model parameters can be given 
to describe the complexity of the model which tries to avoid the over-fitting problem. 
Many sophisticated statistical analyses can be applied on this step to estimate model 
parameters, examine the goodness of fitting, and evaluate the robustness and sensitivity 
of the models. 
 
4.3. Applying the Modeling Roadmap Framework to a New Problem and 
Data Type (Phosphoprotein Expression) 
One of the key aspects of the data-driven modeling framework is its flexibility. As 
described before, bottom-up models are designed for idealized or specific inducers of 
apoptosis, so a model designed for studying a Bax activator would not be applicable to a 
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different kind of inducer such as CCCP. Another significant problem is that they contain 
many variables and parameters, which means that they are “over-fitting” realistic 
experimental data sets. That is, even with substantial adjustments to parameter values or 
the absence or presence of different variables, the models could still fit the data – thus 
their interpretation requires many unjustified assumptions. To show that our framework 
can be generally useful to a variety of biological problems, we employed it on a realistic 
experimental data set from the literature that is specifically focused on the problem of 
identifying hypotheses for the structure of a cellular signaling pathway. This problem 
also had the useful aspect of presenting a data set for phosphoprotein level in cells as 
measured by antibody-labeling and flow cytometry, a common data set encountered in 
drug discovery research. 
 
4.3.1 Challenge Description 
DREAM is a Dialogue for Reverse Engineering Assessments and Methods. The main 
objective is to catalyze the interaction between experiment and computational systems 
biology [102]. DREAM aspires to create a methodology where models are inferred from 
data with a clear quantitative sense of the accuracy of the predictions [102]. To 
accomplish this goal, Gustavo Stolovitzky, et al. come out DREAM challenges each year 
for systems biology researchers to predict biological networks that have already been 
accurately mapped and validated. These challenges can evaluate the accuracy of the 
topology of cellular interactions predicted through reverse engineering algorithms.  
 I participated in ‘Signaling Cascade Identification’, the challenge 1 of DREAM in 
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2008, which explored what key aspects of the dynamics and topology of interactions of a 
signaling cascade can be inferred from incomplete flow cytometry data [103].  As 
shown in Figure 4.2, the concentrations of four intracellular proteins or phospho-proteins 
(X1, X2, X3 and X4) were measured in a portion of a signal transduction cascade in 
primary cells by antibody staining and flow cytometry [103]. These cells were activated 
with ligands for one of their membrane-bound receptors. Two types of ligands: weak and 
strong (i.e., with different potency), and in different quantities, have been used.  
Two data sets were obtained from experimental measurements on individual cells by 
antibody staining and flow cytometry for 4 different proteins or phopshoproteins. 
Depending on the availability of reagents, each file contains measurements on 104 to 105 
cells for the levels of protein Xi (i=1…4) at 5min of activation for one strong ligand and 
seven quantities and one weak ligand and five quantites. Each row represents an 
individual cell, and each entry indicates the fluorescence level in arbitrary units. The 
measurements were taken in the range in which fluorescence is linear with concentration. 
Given the measurements of components X1, X2, X3 and X4, the challenge is to 
determine which of the following functions: kinase, protein, phosphorylated protein, 
phosphatase, activated phosphatase and phosphorylated complex in the signaling cascade 
of the figure correspond to the measured molecular species Xi (i=1…4).  
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Figure 4.2 Schematics of the signaling cascade. A ligand binds to the membrane bound 
receptor creating a complex. Kinase catalyzes the phosphorylation of the complex into 
Phosphorylated Complex. The latter is a catalyst of both the phosphorylation of Protein 
into Phosphorylated Protein, and of Phosphatase into Activate Phosphatase. Activate 
Phosphatase catalyzes the dephosphorylation of Phosphorylated Complex into Complex 
[103].  
 
 
 
4.3.2 Methods and Results 
The mean values were calculated for Xi (i=1…4) from provided data sets. We developed 
a data-driven model using a set of ODEs to describe this signaling cascade shown in 
Figure 4.2.  The Michealis-Menten mechanism was used to describe each biochemical 
reaction. Nine variables were given in the challenge, and seven ODEs were used to 
generate the model. Equation (1) describes the fast receptor-ligand interaction. Equation 
(2) models the signaling cascade through the Complex. Equation (3) describes the 
transition between the Complex and Phosphorylated Complex. Equation (4) models the 
one-way transition between Phosphatase and Activated Phosphatase. Again, we solve 
equations and perform parameter estimation with Matlab 7.0 R14 (The Mathworks, Inc., 
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Natick, MA) running on a PC with a Pentium IV processor. We employ a stiff ODE 
solver (‘ode15s’) and Levenberg-Marquardt nonlinear least squares regression 
(‘lsqcurvefit’) with starting values tested for consistency.  
 
2
1
][
][][
mLigand
Ligandm
dt
Ligandd
+
⋅−=             (1) 
2
1
2
2
1
1
][
][
] [
] []ePhosphatas Activated[
][
][][][
mLigand
Ligandm
ComplexatedPhosphorylk
ComplexatedPhosphorylk
Complexk
KinaseComplexk
dt
Complexd
mm
+
⋅+
+
⋅⋅++
⋅⋅−=
                   (2) 
] [
] []ePhosphatas Activated[
][
][][] [
2
2
1
1
ComplexatedPhosphorylk
ComplexatedPhosphorylk
Complexk
KinaseComplexk
dt
ComplexatedPhosphoryld
m
m
+
⋅⋅−
+
⋅⋅=
      (3) 
][
][] []ePhosphatas Activated[
3
3
ePhosphatask
ePhosphatasComplexatedPhosphorylk
dt
d
m +
⋅⋅=    (4) 
][
][] [][
3
3
ePhosphatask
ePhosphatasComplexatedPhosphorylk
dt
ePhosphatasd
m +
⋅⋅−=     (5) 
][Pr
]Pr [] [4]P[
4 oteink
oteinatedPhosphorylComplexatedPhosphorylk
dt
roteind
m +
⋅⋅−=    (6) 
][Pr
]Pr [] [4]Pr [
4 oteink
oteinatedPhosphorylComplexatedPhosphorylk
dt
oteinatedPhosphoryld
m +
⋅⋅=  
                   (7) 
 
 We firstly employ our modeling roadmap to identify the model variables. There are 
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overall 840 possibilities of identifying four variables from seven candidates. We start our 
roadmap with 840 hypotheses. Instead of intensively computing the model for all 840 
hypotheses, we preliminary identify some variables based on the observation of 
experimental data sets and our domain knowledge in signaling cascade. As shown in 
Figure 4.3 A). the signal for X1 is consistent even the potency of strong ligand increase 
10 time quantitatively. This strongly suggests us that there is no mass conversion for X1. 
Thus, X1 is mostly like to be the Kinase, for kinase just catalyze the reaction. Also, the 
outcome of signal transition in cell biology behaves like a ‘S’ curve verse the enzyme 
doses, as shown in Figure 4.3 B). Therefore, we can make the hypothesis that X4 is the 
Phosphorylated Protein, which is the output of the signal transition system.  
 Indeed, we can reduce 840 hypotheses to 100 hypotheses in which X1 is the Kinase 
and X4 is the Phosphorylated Complex. Following our modeling roadmap, we employ 
the goodness of fittings and robustness of models as the major factors to determine the 
performance of prediction to comparing the differing assumptions. Data set for strong 
ligand was used as “training data” and data set for weak ligand was used as “test data”. 
We fit the model with different identified variables to the training data and calculate the 
AICC scores to evaluate the goodness of fits. Moreover, we also compared the robustness 
performance of models using parameters from training data to fit test data. Figure 4.4 
shows the calculated AICC scores for curve fitting (using parameters from training data to 
fit themselves, i.e. training to training) and Figure 4.5 shows robustness analysis (using 
parameters from training data to fit test data, i.e. training to test).  
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Figure 4.3 Experimental data set for strong ligand at seven doses. A). Plot for X1. B). 
Plot for X4. 
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Figure 4.4 AICC scores of 100 hypotheses for training data (strong ligand). The dash 
red line shows the combination of variables for Xi (i=1~4) has the lowest AICC scores, 
and blue bars show the AICC scores for other combinations of variables.  
 
 
 
Figure 4.5 AICC scores of 100 hypotheses for test data (weak ligand). The dash red 
line shows the combination of variables for Xi (i=1~4) has the lowest AICC scores, and 
blue bars show the AICC scores for other combinations of variables.  
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 The combination of identified variables we selected has lowest AICC scores on both 
determinants. They are X1 for the Kinase, X2 for the Phosphatase, X3 for the Protein, 
and X4 for the Phosphorylated Protein. Figure 4.6 shows the corresponding curves 
generated by the model with identified variables using training data, and Figure 4.7 
shows the corresponding curves generated by the model with identified variables using 
test data. Figure 4.8 shows four examples of randomly picked variable combination with 
strong ligand data, and Figure 4.9 shows four examples of randomly picked variable 
combination with weak ligand data. Compared with the randomly picked variable 
combination, our identified variables definitely fit both training and test data better.  
 
 
 
Figure 4.6 These plots summarize of experimental and modeling results with 
identified variables using strong ligand data.  
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Figure 4.7 These plots summarize of experimental and modeling results with 
identified variables using weak ligand data.  
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Figure 4.8 Four examples of randomly picked variable combination with strong 
ligand data. 
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Figure 4.9 Four examples of randomly picked variable combination with weak ligand 
data. 
 
 
 
 The validation of our modeling methodology on variable identification is conducted 
with the publication of Gregoire Altan-Bonnet’s group in Memorial Sloan-Kettering 
Cancer Center, where the initial data come out [103]. They represented the flow 
cytometric data for the Kinase, Phosphatase, Protein, and Phosphorylated Protein in their 
literature, which are Xi (X1~4). Out predicted results are consistent with their publication. 
This strongly support our modeling methodology can be extendedly applied on 
hypotheses evaluation with realistic experimental data, not only for mechanism model 
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selection, but also for model variable identification. Indeed, out modeling methodology 
can be applied in different area with varied data types. Compared with bottom-up model, 
which is designed for one specific pathway, our data-driven model can be extended to the 
large landscape of biology research.  
 Multiple models with different mathematical formulations were initially developed 
and compared. The selected model using equation (1) ~ (7)  performs best on both 
training data and test data. Other models have obvious bad fittings on one or several 
variables. Based on the observation on both training data and test data and their 
corresponding AICc scores, we select the model using the formulations which can 
represent the data best.  
 
4.3.3 Model Improvement 
4.3.3.1 Parameter Estimation Sensitivity Analysis for Selected Models 
Similarly as described in 3.4.5, we evaluated the consistency of parameter 
estimation to examine the possible local optimum problem. We employed the Latin 
Hypercube sampling to generate 100 different initial parameter vectors with range 
between 0 to 5. The normalized values of estimated parameters with these 100 different 
initial vectors were calculated by (Max-Min)/Avg, as shown in Figure 4.10. m1, m2, k1, 
k1m, k2, k2m, k3, k3m, k4, k4m are the parameters described in equations (1) ~(7).  
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Figure 4.10 Stability analysis of parameter estimation.  
 
 
 
As represented in Figure 4.10, k2m, k3, and k4m are more sensitive to different initial 
vectors, which suggest us that there might be more complex signal pathway models 
involved in the chemical reaction processes, including Phosphorylated Complex to 
Complex transition, Phosphatase to Activated Phosphatase transition and Protein to 
Phosphorylated Protein transition. To analyze the determinability of parameters, the 
correlation coefficients between each pair of estimated parameters were calculated and 
plotted in Figure 4.11. There is high correlation between k3, and k4. Since k3 represent the 
transition from Phosphatase to Activated Phosphatase and k4 represents the transition 
from Protein to Phosphorylated Protein, this suggests us that the Phosphorylated 
Complex plays the key roles to activate these two reactions.  
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Figure 4.11 Correlation analysis for the stability analysis of parameter estimation.  
 
 
 
The parameter estimation sensitivity analysis shown in Figure 4.10 indicates that 
more complex models with detailed signal pathways can further explain the single 
cascade if more experimental data can be provided. The high correlated parameters in 
different equations shown in Figure 4.11 suggests that some terms or process of the 
model might be simplified if the high correlated parameters are from the same term, as 
described in Chapter 3. In this case, the parameters are identifiable based on the limited 
experimental data. 
 
4.3.3.2 Parameter Sensitivity Analysis by Finite Difference Method 
This competition challenge was designed from a realistic biological problem described by 
Feinerman, O., et al [103]. As shown in Figure 4.12, the Feinerman group measures the 
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protein expression level for the T lymphocyte in the immune system. The signaling 
transition is activated by T cell receptor (TCR) and the co-receptor cluster of 
differentiation 8 (CD8) binding to the peptide-bound major histocompatability complex 
class I (pMHC). Two feedbacks mediate this signaling transition. The negative feedback 
is initiated by the soluble hematopoietic phosphatase 1 (SHP-1), and limits the formation 
of phosphorylated complex. The positive feedback is activated by the extracellular 
signal–regulated kinase 1 (ERK-1).  
 
 
 
 
Figure 4.12 Schematics of the signaling cascade with identified variables.  
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Table 4.1 Identities of variables of signaling cascade challenge in the realistic 
biology problem.  
Variables in Challenge Variables in Realistic Biological Problem Brief Description 
Receptor 
peptide-bound major 
histocompatability 
complex class I (pMHC) 
It is a large genomic region that 
encodes heterodimeric 
peptide-binding proteins and 
plays an important role in the 
immune system. 
Ligand T cell receptor (TCR) It is a molecule found in T lymphocytes. 
Kinase Cluster of Differentiation 8 (CD8) It is a co-receptor for TCR. 
Phosphatase Soluble Hematopoietic Phosphatase 1 (SHP-1) 
It is a protein that inhibits the 
signaling cascades in 
hematopoietic cells 
Protein 
Extracellular 
Signal-Regulated Kinases 
(ERK) 
It is a group of kinases that 
regulate signaling transition.  
Phosphorylated 
Protein pp-ERK 
It is the dual-phosphorylated 
active form of ERK 
(pTpY-ERK) 
 
 
 
The model sensitivity matrix was calculated as described in Chapter 3. Figure 4.13 ~ 
Figure 4.16 show the dependence of identified variables on changes in each of teen 
parameters at six different doses for the strong ligand. Parameters 1~10 represent m1, m2, 
k1, k2, k3, k4, k1m, k2m, k3m, k4m consequentially. Figure 4.16 describes the 
sensitivity-dependent correlation matrix between each pair of parameters.  
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Figure 4.13 Parameter sensitivity analysis of the model variable CD8. 
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Figure 4.14 Parameter sensitivity analysis of the model variable SHP-1. 
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Figure 4.15 Parameter sensitivity analysis of the model variable ERK. 
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Figure 4.16 Parameter sensitivity analysis of the model variable pp-ERK 
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Figure 4.17 Parameter Sensitivity Analysis of the model variables.  
 
 
  
As shown in Figure 4.13, Kinase, which is CD8, is not sensitivity for any parameters 
at any ligand doses. Since CD8 is a kind of enzyme which only transfers molecules and 
catalyzes biochemical reactions, it isn’t consumed by the reactions. As shown in Figure 
4.14, Phosphatase, which is SHP-1, is more sensitive with k2, which is the production 
term for the negative feedback transition, especially for the high dose ligand treatment. 
Compared with SHP-1, the variables of positive feedback, ERK-1 and phosphorylated 
ERK-1 are more sensitive with parameters k1, k2, k4, which are the dominant factors to 
regulate signaling transition and the positive feedback on signaling cascade. 
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
 
 
5.1 Overall Conclusions for Microtubule Modeling (Chapter 2) 
We developed a methodology here that can be used to compare model predictions with 
experimental data. Our model is a hybrid of (1) a simple two-state stochastic formulation 
of tubulin polymerization kinetics and (2) an equilibrium approximation for the chemical 
kinetics of Taxol drug binding to microtubule ends. Model parameters are biologically 
realistic, with values taken directly from experimental measurements. Model validation is 
conducted against published experimental data comparing optical measurements of 
microtubule dynamics under normal and Taxol-treated conditions. To compare model 
predictions with experimental data requires applying a “windowing” strategy on the 
spatiotemporal resolution of the simulation. From a biological perspective, this is 
consistent with interpreting the microtubule “pause” phenomenon at least partially the 
result of spatiotemporal resolution limits on experimental measurement rather than 
tubulin biochemistry. Though our work provides the theoretical interpretations without 
further experiments so far, it can be extended with the incorporate forces and protein 
components that interact with microtubules.  
 
5.2 Overall Conclusions for the Analysis of ROS-Induced Cell Death 
(Chapters 3 and 4) 
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Overall, our model understands how cell death stimulated by CCCP and what are the 
dynamic interactions between system variables. Compared with the detailed mechanism 
models for cell death pathways, this ‘data-driven’ model is more robust and can be 
generally applied to a different kind of inducer/drug. The basic approach we describe can 
be easily applied to any cell-based measurements of other variables such as intracellular 
PH, expression of proteins tagged with GFP (green fluorescent protein), or intracellular 
protein concentration measured by antibody staining of fixed cells. 
Most importantly, compared with the traditional approach to cell-based assays, we 
develop a realistic approach to study the perturbation of biological systems, including 
data processing and quantification, model development, parameter estimation, and 
robustness analysis. Our approach can be extended to any study on the perturbation of 
biological systems, and it will be useful in similar cases with limited data obtained 
through the use of fluorescent markers. As shown in Figure 18, we start with limited 
experimental data from cell-based screens. We consider a set of chemicals that are 
potential drugs to perturb cell systems. Then, using the modeling roadmap we have 
proposed here, we develop the broad set of potential models, compare the different 
hypothesis behind the models, and select the optimal hypothesis for more costly specific 
experimental testing to scale down to identifying signaling pathways. After several loops, 
we can identify the target and scale up to in vivo test. 
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Figure5.1 Schematic of an overall drug discovery research approach that integrates 
high-throughput experiments with data-driven modeling.  
 
 
 
5.3 Towards a Formal Integrative Framework for Modeling and 
Experimental Design  
The rapid development of biotechnology of the last decade has broadly expanded the 
landscape of biological research [102, 104].  The need to model complex cell processes 
at many different scales requires quantitative measurements from experimental 
techniques in cell biology and mathematical modeling approaches to organize and 
structure information, test and validate hypotheses for the new phenomena [97, 98]. 
Integrated experimental design and computational modeling have a long tradition in life 
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sciences, engineering, statistics, mathematics, computational algorithms, and information 
technologies, as reviewed in [97, 98]. In this thesis, we focus on the problem of starting 
with limited information and experimental data and maximizing understanding and 
predicting the dynamic behavior of cellular systems using an optimal combination of 
stimulations and observations over times.   
 Fundamentally, biologists study systems through hypothesis generation and testing. 
Experiments are designed to maximize the distinction between a “yes” or “no” outcome, 
not to generate high-precision numbers to validate a quantitative theory. This is even true 
when quantitative data are obtained, for example from physiological measurements. 
Many chemical kinetics models are based on parameters obtained consequentially in 
biochemical experiments, for example [105, 106]. A proper experimental design can be 
extract the maximum information from analysis, whereas an improper design cannot be 
compensated by sophisticated analysis methods [10, 98].  
 Experimental design is based on hypotheses from prior knowledge about a system 
based on literature and preliminary tests. One key problem that arises during 
experimental design is that hypotheses evaluation through experimental trials is limited 
by constraints of time, funding, availability of experimental technology that can make 
sufficiently accurate measurement, and the frequent need to destroy samples that are 
being measured, which hurts repeatability and precision of data. Another significant 
problem is that we must design experiments with an appropriate scope and level of detail. 
One single assay will not be sufficient to understand a complex biological phenomenon. 
Experiments are designed based on an experimental model of a system that contains 
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variables that will be tested to elucidate their interactions and the parameters of their 
interactions. One point of view holds that the experimental model of a system should 
include all known system components so as to accurately evaluate the proposed 
hypotheses. However, as we learn more about cellular systems, we realize that there are 
so many components involved that it would be impossible to measure all of system 
parameters with sufficient accuracy and precision given practical limits on time and 
resources. (New technologies such as genomics and proteomics may allow us to identify 
the genes and proteins that are involved in a system, but they are far too noisy and costly 
to obtain accurate data on temporal behavior.) Moreover, obtaining data for a system 
from various techniques applied independently has difficulty in obtaining reproducible 
temporal dynamics [107].  
 Besides the problem of experimental design itself, the use of mathematical modeling 
approaches raises its own new demands on experimental planning.  Specifically, the 
application of mathematical modeling for testing and validation of hypotheses is critical 
for the prediction of new phenomena, such as how a cell will respond to the application 
of a novel drug. Besides the methods described in this thesis, a continuously expanding 
diversity of bioinformatics algorithms and approaches and have been developed to 
discover emerging biological properties in cell systems and be used to facilitate drug 
discovery (as briefly summarized in Chapter 4.2). The basic goal of all these 
approaches is to investigate the complementary combination of experimental design and 
mathematical modeling to maximally extract information and increase the understanding 
of cellular systems. As shown in Figure 5.2, researchers start with limited preliminary 
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experimental data and develop all possible biological hypotheses behind the observations.  
Mathematical and computational approaches are employed to evaluate and select the best 
hypothesis, and move biology from a descriptive to a predictive science [10]. The 
selected hypothesis is validated through experimental or clinic trials, and generates more 
information to understand cellular systems. After several cycles, the researchers can 
translate data to ideas.   
 
 
 
Figure 5.2 Once they can integrating experimental and theoretical modeling, 
researchers can then identify the optimal combination of simulations and observations. 
The result is an efficiently updating “knowledge cycle”. 
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